GLP-1 Market
LLY $1183.46 ▲ +0.1% NVO $38.80 ▲ +0.5% PFE $28.67 ▲ +0.9% VKTX $35.56 ▼ -3.2% KLRA $11.21 ▼ -6.4% GPCR $35.93 ▼ -0.2% RHHBY $54.41 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Polyethylene Glycol 3350

Company
General Hospital of Shenyang Military Region
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
37 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

37 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 26, 2026

Find a Clinical Trial Near Me

See recruiting studies for Polyethylene Glycol 3350 and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00501826

    Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

    Not yet reported M.D. Anderson Cancer Center 160 participants Est. completion 2026-10-31 1 site
    Other conditions: T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT03687814

    Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation

    Not yet reported University of Michigan 78 participants Est. completion 2026-01 1 site Stand-alone
    Other conditions: Irritable Bowel Syndrome Characterized by Constipation
    View official trial listing →
  • Recruiting NCT NCT04019548

    Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy

    Not yet reported Jules Bordet Institute 110 participants Est. completion 2030-05-01 2 sites Stand-alone
    Other conditions: Oropharyngeal Cancer
    View official trial listing →
  • Recruiting NCT NCT04110613

    RCT: Early Feeding After PEG Placement

    Not yet reported Carilion Clinic 1200 participants Est. completion 2026-09-30 1 site
    Other conditions: Critical Illness, Malnutrition, Gastrostomy, Procedural Sequelae, Trauma, Surgery, Mechanical Ventilation
    View official trial listing →
  • Recruiting NCT NCT04436965

    Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition

    Not yet reported Sun Yat-sen University 266 participants Est. completion 2029-12 1 site Stand-alone
    Other conditions: Nasopharyngeal Carcinoma, Nutrition Therapy
    View official trial listing →
  • Recruiting NCT NCT04684368

    A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

    Not yet reported Children's Oncology Group 160 participants Est. completion 2029-12-21 170 sites
    Other conditions: Central Nervous System Nongerminomatous Germ Cell Tumor, Choriocarcinoma, Embryonal Carcinoma, Immature Teratoma, Malignant Teratoma, Mixed Germ Cell Tumor, Pineal Region Germ Cell Tumor, Pineal Region Immature Teratoma, Pineal Region Yolk Sac Tumor, Suprasellar Germ Cell Tumor
    View official trial listing →
  • Recruiting NCT NCT04991025

    Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

    Not yet reported Memorial Sloan Kettering Cancer Center 60 participants Est. completion 2026-10 7 sites
    Other conditions: Lung Cancer, Lung Cancer Stage II, Lung Cancer Stage III
    View official trial listing →
  • Recruiting NCT NCT05336760

    Dysphagia, QoL and Attitudes Towards PEG in ALS Patients

    University Rehabilitation Institute, Republic of Slovenia 60 participants Est. completion 2026-09-30 1 site
    Other conditions: Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Recruiting NCT NCT05392387

    Treatment and Prognosis of Patients With Chronic HBV Infection

    Xiangya Hospital of Central South University 500 participants Est. completion 2026-10-25 1 site
    Other conditions: Hepatitis B Virus Infection
    View official trial listing →
  • Recruiting NCT NCT05771402

    A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B)

    Not yet reported The Second Affiliated Hospital of Chongqing Medical University 120 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNα
    View official trial listing →
  • Recruiting NCT NCT05821309

    Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen

    Not yet reported Indiana University 65 participants Est. completion 2027-07 2 sites Stand-alone
    Other conditions: Constipation
    View official trial listing →
  • Recruiting NCT NCT05959720

    Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil

    Instituto do Cancer do Estado de São Paulo 180 participants Est. completion 2030-06 1 site
    Other conditions: Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality, Chemotherapeutic Toxicity
    View official trial listing →
  • Recruiting NCT NCT06034561

    Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic Leukemia

    Not yet reported Instituto do Cancer do Estado de São Paulo 50 participants Est. completion 2029-08 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission
    View official trial listing →
  • Recruiting NCT NCT06110910

    Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)

    Xiaoping Luo 10000 participants Est. completion 2027-12-31 1 site
    Other conditions: Childhood Short Stature
    View official trial listing →
  • Recruiting NCT NCT06298461

    Bowel Preparation for Colonoscopy Among Individuals With Crohn's and Ulcerative Colitis Disease.

    Not yet reported University of Manitoba 418 participants Est. completion 2026-05 1 site
    Other conditions: Crohn Disease, Ulcerative Colitis
    View official trial listing →
  • Recruiting NCT NCT06336395

    Ma-Spore ALL 2020 Study

    Not yet reported National University Hospital, Singapore 500 participants Est. completion 2030-03 3 sites Stand-alone
    Other conditions: B Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT06361498

    Ultrasound for Evaluation of Percutaneous G-tube Position

    Not yet reported University of North Carolina, Chapel Hill 10 participants Est. completion 2027-06 1 site
    Other conditions: Gastrostomy
    View official trial listing →
  • Recruiting NCT NCT06455813

    What Laxative Should be Used After Hip Fracture Surgery?

    Not yet reported Odense University Hospital 375 participants Est. completion 2027-01-31 2 sites
    Other conditions: Hip Fractures
    View official trial listing →
  • Recruiting NCT NCT06563869

    Sintilimab With Chemotherapy Plus PEG-rhG-GSF for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 40 participants Est. completion 2026-11-22 1 site Stand-alone
    Other conditions: Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06598007

    A Study to Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

    Not yet reported, Not yet reported Crossignal Therapeutics, Inc. 78 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Solid Tumor, Adult, Colorectal Cancer, Pancreatic Ductal Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT06652906

    Study on the Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in People Aged 50 to 70 Years Old

    Not yet reported RenJi Hospital 8 participants Est. completion 2024-12-01 1 site
    Other conditions: Physical Examination
    View official trial listing →
  • Recruiting NCT NCT06738368

    Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia

    Not yet reported University of Washington 30 participants Est. completion 2028-07-30 1 site
    Other conditions: B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia
    View official trial listing →
  • Recruiting NCT NCT06746701

    Study on the Treatment of Hepatitis B Virus(HBV) Infected Individuals With Peginterferon α-2b Combined With NA.

    Xiangya Hospital of Central South University 400 participants Est. completion 2029-05-25 4 sites
    Other conditions: HBV
    View official trial listing →
  • Recruiting NCT NCT06775925

    Robot-assisted vs. Conventional Occupational Therapy of the Upper Limb in Individuals With Cervical Spinal Cord Injury

    Not yet reported Swiss Paraplegic Research, Nottwil 40 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Cervical Spinal Cord Injury
    View official trial listing →
  • Recruiting NCT NCT06923280

    Sequential PEG-IFN for HBV After Ending RNA-targeted Regimens

    Not yet reported Huashan Hospital 72 participants Est. completion 2029-05-31 2 sites Stand-alone
    Other conditions: Hepatitis B, Chronic
    View official trial listing →
  • Recruiting NCT NCT06923813

    Assessment of Nutrient Absorption in Enterally Fed Post-intensive Care Unit Patients Using Bomb Calorimetry: do the Calories Stick

    Not yet reported Universitair Ziekenhuis Brussel 20 participants Est. completion 2028-04-01 2 sites Stand-alone
    Other conditions: Post-ICU Patients Fully Enterally Fed
    View official trial listing →
  • Recruiting NCT NCT07079150

    Real-world Study Evaluating the Long-term Outcomes of Pegylated Interferon α-2b Treatment in the Families With Clusters of HBV Infection and Unfavorable Prognosis - A Prospective, Controlled, Multicenter, Cohort Study

    First Affiliated Hospital Xi'an Jiaotong University 1500 participants Est. completion 2032-01 2 sites
    Other conditions: Hepatitis B, Chronic (CHB), Hepatitis B, Hepatitis B Virus (HBV)
    View official trial listing →
  • Recruiting NCT NCT07193303

    Mental Imagery on Upper Extremity Skills

    Not yet reported Kahramanmaras Sutcu Imam University 30 participants Est. completion 2027-01-30 1 site Stand-alone
    Other conditions: PARKINSON DISEASE (Disorder), Mental Imagery, Motor Imagery
    View official trial listing →
  • Recruiting NCT NCT07218523

    A Study to Investigate Bowel Cleansing With PLENVU® Compared to Sodium Picosulfate in Participants Aged 1 to < 18 Years of Age in Preparation for Colonoscopy

    Not yet reported Norgine 212 participants Est. completion 2027-01-06 41 sites
    Other conditions: Bowel Cleansing Prior to Clinical Procedures
    View official trial listing →
  • Recruiting NCT NCT07353853

    Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease

    Not yet reported Changhai Hospital 1000 participants Est. completion 2026-06-30 1 site
    Other conditions: IBD (Inflammatory Bowel Disease), Colonoscopy, Colonoscopy: Bowel Preparation
    View official trial listing →
  • Recruiting NCT NCT07513727

    Vitamin C for Gingival Depigmentation

    Not yet reported Al-Azhar University 30 participants Est. completion 2026-05-01 1 site Stand-alone
    Other conditions: Gingival Hyperpigmentation, Gingival Melanin Pigmentation
    View official trial listing →
  • Recruiting NCT NCT07520721

    Poly vs Hybrid Glenoid in Stemless aTSA

    Not yet reported Spaarne Gasthuis 94 participants Est. completion 2036-12 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Recruiting NCT NCT07525466

    Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH)

    Not yet reported, Not yet reported Beijing Tongren Hospital 25 participants Est. completion 2028-09-30 1 site Stand-alone
    Other conditions: Extranodal NK T Cell Lymphoma, Hemophagocytic Lymphohistiocytosis (HLH)
    View official trial listing →
  • Recruiting NCT NCT07557173

    Comparing Three Rescue Bowel Preparation Regimens for Colonoscopy After Failed Cleansing

    Not yet reported Ospedale San Pio 220 participants Est. completion 2026-06 1 site
    Other conditions: Bowel Cleansing for Colonoscopy, Inadequate Bowel Preparation
    View official trial listing →
  • Recruiting NCT NCT07608120

    Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation

    Not yet reported Nanfang Hospital, Southern Medical University 405 participants Est. completion 2027-05-31 1 site Stand-alone
    Other conditions: Colonoscopy, Bowel Preparation Solutions, Colorectal Cancer Screening
    View official trial listing →
  • Recruiting NCT NCT07623200

    A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia

    Not yet reported Incyte Corporation 426 participants Est. completion 2030-11-01 175 sites
    Other conditions: Essential Thrombocythemia
    View official trial listing →
  • Recruiting NCT NCT07769827

    Peg IFNα-2b Therapy for Unresectable Mid to Late Stage HBV-HCC

    Not yet reported Jinling Hospital, China 33 participants Est. completion 2029-03-01 1 site Stand-alone
    Other conditions: HBV-HCC, Unresectable Advanced HBV-related Liver Cancer
    View official trial listing →
  • Completed NCT NCT00001255

    Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) Due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study

    National Human Genome Research Institute (NHGRI) 10 participants Est. completion 2002-07 1 site
    Other conditions: Severe Combined Immunodeficiency
    View official trial listing →
  • Completed NCT NCT00001997

    Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals

    Not yet reported Chiron Corporation 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00005945

    Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia

    Not yet reported Children's Oncology Group 3054 participants Est. completion 2008-06 130 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00008463

    A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 132 participants Est. completion 2006-08 24 sites
    Other conditions: HIV Infections, Hepatitis C
    View official trial listing →
  • Completed NCT NCT00014261

    Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors

    Not yet reported Dartmouth-Hitchcock Medical Center Est. completion 2002-11 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00039962

    Thymosin Plus PEG-Interferon in Hepatitis C Patients With Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin

    Not yet reported SciClone Pharmaceuticals 500 participants 56 sites
    Other conditions: Hepatitis C, Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT00040027

    Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

    Not yet reported SciClone Pharmaceuticals 500 participants 48 sites
    Other conditions: Hepatitis C, Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT00045279

    PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2005-09 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00075725

    Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia

    Not yet reported Children's Oncology Group 3154 participants Est. completion 2021-03-31 234 sites
    Other conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00077623

    A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.

    Not yet reported Hoffmann-La Roche 572 participants Est. completion 2005-09 90 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00100659

    PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 114 participants Est. completion 2010-02 11 sites
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00101010

    Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

    Not yet reported M.D. Anderson Cancer Center 80 participants Est. completion 2014-09 7 sites
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00103285

    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported Children's Oncology Group 5377 participants Est. completion 2021-03-31 236 sites
    Other conditions: Acute Lymphoblastic Leukemia, Childhood B Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00114361

    48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

    Not yet reported Foundation for Liver Research 138 participants Est. completion 2010-04 1 site
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT00148837

    Efficacy of Prazosin Versus Placebo Associated With Peg-interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe Fibrosis

    Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 112 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Hepatitis C, Chronic, Fibrosis
    View official trial listing →
  • Completed NCT NCT00152386

    A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis

    Not yet reported UCB Pharma 950 participants Est. completion 2006-10 76 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00155415

    A Prospective Single-Blinded Randomized Trial Comparing Colonoscopic Preparation at Different Time

    Not yet reported National Taiwan University Hospital 120 participants Est. completion 2005-09 1 site
    Other conditions: Colonoscopy, Colon Neoplasm
    View official trial listing →
  • Completed NCT NCT00158496

    Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)

    Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 100 participants Est. completion 2005-01 2 sites
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00160524

    A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]

    Not yet reported UCB Pharma SA 596 participants Est. completion 2012-08 206 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00160602

    A Study of Liquid Certolizumab Pegol as Additional Medication to Methotrexate in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis

    Not yet reported UCB Pharma 590 participants Est. completion 2006-09 70 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00160706

    A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease

    Not yet reported UCB Pharma SA 310 participants Est. completion 2012-05 141 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00166296

    Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients

    Not yet reported Germans Trias i Pujol Hospital 133 participants Est. completion 2007-10 15 sites
    Other conditions: Major Depressive Disorder, Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT00189137

    Evaluation of Side Effects and Relative Activity of Two Chemotherapy Regimens in the Treatment Soft Tissue Sarcoma

    Not yet reported University of Michigan Rogel Cancer Center 84 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Sarcoma, Soft Tissue
    View official trial listing →
  • Status unknown NCT NCT00192673

    Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses

    Not yet reported Nordic Society for Pediatric Hematology and Oncology 85 participants Est. completion 2013-12 1 site
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00207363

    Does Induction PEG-Intron in Combination With Rebetol Enhance the Sustained Response Rates in Patients With CHC

    Not yet reported Brooke Army Medical Center 610 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT00222612

    Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003

    Not yet reported University of Oxford 2100 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00238329

    PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma

    Not yet reported Barbara Ann Karmanos Cancer Institute 32 participants Est. completion 2007-06 1 site
    Other conditions: Intraocular Melanoma, Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00255372

    To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.

    Not yet reported Ipsen 88 participants Est. completion 2008-05-20 2 sites Stand-alone
    Other conditions: Chronic Constipation
    View official trial listing →
  • Completed NCT NCT00276354

    Study of Long-term Use of Forlax® in Elderly Patients With Chronic Constipation

    Not yet reported Ipsen 246 participants Est. completion 2001-11-20 146 sites
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT00276523

    PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery

    Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2006-03 1 site Stand-alone
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Terminated NCT NCT00279565

    Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)

    Not yet reported Indivior Inc. 128 participants Est. completion 2007-02
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Status unknown NCT NCT00297570

    Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

    Not yet reported Sheba Medical Center 90 participants 1 site
    Other conditions: Leukemia, Myeloid, Philadelphia-Positive
    View official trial listing →
  • Completed NCT NCT00297648

    Mucosal Healing Study in Crohn's Disease (CD)

    Not yet reported UCB Pharma 89 participants Est. completion 2009-12 19 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00319670

    A Pilot Study of a New MiraLax® Dose Formulation For Use in Constipated Children

    Not yet reported Braintree Laboratories 25 participants 2 sites
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT00322062

    MOVIPREP® Versus NaP Pivotal Phase III Study

    Not yet reported Norgine 340 participants Est. completion 2003-03 18 sites Stand-alone
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT00323505

    A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma

    Not yet reported Royal Marsden NHS Foundation Trust Est. completion 2004-12 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00327535

    A Study of Mircera in Anemic Patients With Non-Small Cell Lung Cancer Receiving First Line Chemotherapy.

    Not yet reported Hoffmann-La Roche 153 participants Est. completion 2007-05 68 sites
    Other conditions: Anemia
    View official trial listing →
  • Terminated NCT NCT00349752

    Corticosteroid Sparing Effect of Certolizumab in Crohn's Disease

    Not yet reported UCB Pharma 174 participants Est. completion 2009-07 68 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00353418

    A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

    Not yet reported Hoffmann-La Roche 415 participants Est. completion 2009-04 Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Withdrawn NCT NCT00354367

    Evaluate Efficacy of Certolizumab in Crohn's Patients With Draining Fistulas

    Not yet reported UCB Pharma
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT00357994

    Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

    Not yet reported AbbVie (prior sponsor, Abbott) 36 participants Est. completion 2011-10 15 sites Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Withdrawn NCT NCT00358683

    A Trial Evaluating Safety of Chronic Therapy With Certolizumab Pegol in Crohn's Disease

    Not yet reported UCB Pharma
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00366548

    Study to Evaluate a 13-valent Pneumococcal Conjugate Vaccine in Infants

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 500 participants Est. completion 2008-06 14 sites
    Other conditions: Vaccines, Pneumococcal
    View official trial listing →
  • Completed NCT NCT00371761

    PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)

    Not yet reported Merck Sharp & Dohme LLC 25 participants Est. completion 2009-02
    Other conditions: Hepatitis B, Chronic (CHB)
    View official trial listing →
  • Completed NCT NCT00377910

    The Efficacy of Polidocanol Injections as a Treatment of Chronic Achilles. Tendinopathy

    Not yet reported Northern Orthopaedic Division, Denmark 48 participants Est. completion 2009-01 1 site
    Other conditions: Chronic Achilles Tendinopathy
    View official trial listing →
  • Completed NCT NCT00381953

    High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV

    Not yet reported Foundation for Liver Research 33 participants Est. completion 2006-07 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00389233

    A Phase III Trial to Assess the Efficacy, Acceptability and Safety of Moviprep® Versus a 4L PEG+E Standard Solution

    Not yet reported Norgine 360 participants Est. completion 2002-12 12 sites Stand-alone
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT00389311

    A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides

    Not yet reported Johns Hopkins University 12 participants Est. completion 2009-06 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00390598

    PEG Solution (Laxabon®) 4L Versus Senna Glycoside (Pursennid® Ex-Lax) 36mg and PEG Solution (Laxabon®) 2L for Large Bowel Cleansing Prior to Colonoscopy

    Not yet reported, Not yet reported Umeå University 490 participants Est. completion 2006-12 1 site
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT00403819

    Study to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children

    Not yet reported Norgine 60 participants Est. completion 2003-04 6 sites
    Other conditions: Chronic Constipation
    View official trial listing →
  • Completed NCT NCT00403897

    An Open Single Centre Study To Assess Treatment of Chronic Constipation in Children

    Not yet reported Norgine 81 participants Est. completion 2003-01 1 site Stand-alone
    Other conditions: Chronic Constipation
    View official trial listing →
  • Completed NCT NCT00408005

    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

    Not yet reported National Cancer Institute (NCI) 1895 participants Est. completion 2025-03-31 215 sites
    Other conditions: T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
    View official trial listing →
  • Terminated NCT NCT00412750

    Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)

    Not yet reported Novartis 159 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT00420784

    A Study of Telaprevir (VX-950), Pegasys and Copegus in Hepatitis C (PROVE3)

    Not yet reported Vertex Pharmaceuticals Incorporated 465 participants Est. completion 2009-04 53 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00423670

    Safety and Efficacy of SCH 503034 in Previously Untreated Subjects With Chronic Hepatitis C Infected With Genotype 1 (Study P03523)

    Not yet reported Merck Sharp & Dohme LLC 765 participants Est. completion 2008-11 Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00423865

    Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2011-09 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00440726

    Bortezomib With Chemotherapy for Relapsed Pediatric Acute Lymphoblastic Leukemia (ALL)

    Not yet reported, Not yet reported Therapeutic Advances in Childhood Leukemia Consortium 31 participants Est. completion 2011-02-26 24 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00452023

    Pegasys® in Patients With Myeloproliferative Diseases

    Not yet reported M.D. Anderson Cancer Center 83 participants Est. completion 2023-05-26 1 site
    Other conditions: Myeloproliferative Disorders
    View official trial listing →
  • Terminated NCT NCT00467077

    Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer

    Not yet reported California Cancer Consortium 21 participants Est. completion 2011-03 3 sites Stand-alone
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00476190

    ALL Adult Consortium Trial: Adult ALL Trial

    Not yet reported Dana-Farber Cancer Institute 112 participants Est. completion 2020-03 15 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00493662

    Cross-Over Evaluation of Two Lubricating Eye Drops

    Not yet reported Innovative Medical 1 site
    Other conditions: Dry Eye
    View official trial listing →
  • Completed NCT NCT00494949

    Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients

    Not yet reported, Not yet reported Sangart 30 participants Est. completion 2006-08 2 sites
    Other conditions: Hypotension, Hypoxia
    View official trial listing →
  • Completed NCT NCT00503815

    BLI-800-302: BLI-800 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

    Not yet reported Braintree Laboratories 360 participants Est. completion 2007-11 10 sites
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT00525031

    Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients

    Not yet reported M.D. Anderson Cancer Center 55 participants Est. completion 2016-06 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00528528

    An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants

    Not yet reported Tibotec BVBA 166 participants Est. completion 2009-08 24 sites Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00544154

    Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis

    Not yet reported UCB Pharma 247 participants Est. completion 2004-01
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00548847

    Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation

    Not yet reported Emory University 15 participants Est. completion 2015-03 1 site
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00550680

    A Study of Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia

    Not yet reported Hoffmann-La Roche 208 participants Est. completion 2009-09 24 sites
    Other conditions: Chronic Renal Anemia
    View official trial listing →
  • Completed NCT NCT00557193

    Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported Children's Oncology Group 218 participants Est. completion 2024-06-30 170 sites
    Other conditions: Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Childhood T Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00559273

    A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on Dialysis

    Not yet reported Hoffmann-La Roche 307 participants Est. completion 2009-10 76 sites
    Other conditions: Renal Anemia, Chronic
    View official trial listing →
  • Completed NCT NCT00570843

    Masked Comparison of a New PEG Based Artificial Tear and Optive for Comfort, Vision & Wear Time in Patients Wearing Contact Lenses

    Not yet reported Bp Consulting, Inc 50 participants Est. completion 2010-02 1 site
    Other conditions: Comfort, Vision and Wear Time
    View official trial listing →
  • Completed NCT NCT00574730

    CHOP/Rituximab Followed by Maintenance PEG Intron in Treatment of Indolent/Follicular Non-Hodgkin's Lymphoma

    Not yet reported University of Nebraska 27 participants Est. completion 2012-06-07 1 site Stand-alone
    Other conditions: Non-Hodgkins Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00575627

    Pegylated-Interferon and Ribavirin in Hepatitis C Patients With Persistently Normal Alanine Aminotransferase Levels

    Not yet reported University of Turin, Italy 150 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT00603681

    Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation

    Not yet reported Orion Corporation, Orion Pharma 67 participants Est. completion 2008-07 10 sites Stand-alone
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT00611442

    Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy

    Not yet reported Brooke Army Medical Center 191 participants Est. completion 2008-01 1 site
    Other conditions: Bowel Preparation for Colonoscopy
    View official trial listing →
  • Completed NCT NCT00622037

    Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

    Not yet reported Bp Consulting, Inc 70 participants Est. completion 2008-05 1 site
    Other conditions: Dry Eye
    View official trial listing →
  • Completed NCT NCT00627302

    Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

    Not yet reported Bp Consulting, Inc 40 participants Est. completion 2008-11 1 site
    Other conditions: Myopia
    View official trial listing →
  • Completed NCT NCT00629967

    A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for HCV Genotype-1 Patients

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 200 participants Est. completion 2007-05 1 site
    Other conditions: Chronic Hepatitis C, Genotype
    View official trial listing →
  • Completed NCT NCT00630058

    A Phase 1 Study of MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

    Not yet reported Tanabe Pharma Corporation 20 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00633659

    Pilot Study of Hemospan® in Patients With Chronic Critical Limb Ischemia

    Not yet reported Sangart 6 participants Est. completion 2008-12 1 site
    Other conditions: Vascular Disease, Critical Lower Limb Ischemia
    View official trial listing →
  • Completed NCT NCT00642304

    A Study of Subcutaneous C.E.R.A. for the Maintenance of Hemoglobin Levels in Participants With Chronic Renal Anemia Not on Dialysis.

    Not yet reported Hoffmann-La Roche 20 participants Est. completion 2009-12-09 23 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00642668

    A Study of Subcutaneous Mircera for the Maintenance Treatment of Participants With Chronic Renal Anemia

    Not yet reported Hoffmann-La Roche 35 participants Est. completion 2009-12-31 32 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00642850

    STABIL Study: National Study With Mircera for Maintenance of Hemoglobin Level in Dialysis Patients

    Not yet reported Hoffmann-La Roche 188 participants Est. completion 2009-07 24 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00681265

    Tear Film Break-up Time After Instillation of Artificial Tears

    Not yet reported Calm Water Therapeutics LLC 16 participants Est. completion 2008-08 1 site
    Other conditions: Keratoconjunctivitis Sicca
    View official trial listing →
  • Completed NCT NCT00699348

    A Study of Monthly Intravenous C.E.R.A. (Mircera) in Hemodialysis Participants With Chronic Renal Anemia

    Not yet reported Hoffmann-La Roche 351 participants Est. completion 2010-07 60 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00703118

    A Safety and Effectiveness Study of Telaprevir in Chronic, Genotype 1, Hepatitis C Patients That Failed Previous Standard Treatment

    Not yet reported Tibotec BVBA 663 participants Est. completion 2010-07 91 sites Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT00704184

    Safety and Efficacy of Vaniprevir (MK7009) Administered With Pegylated-Interferon and Ribavirin (MK-7009-007)

    Not yet reported Merck Sharp & Dohme LLC 95 participants Est. completion 2010-04-14 Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00704340

    DuraSeal Sealant Post Market Study

    Not yet reported Integra LifeSciences Corporation 237 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Elective Cranial Procedures With Dural Incision
    View official trial listing →
  • Completed NCT NCT00708201

    A Study of Alvimopan for the Management of Postoperative Ileus in Participants Undergoing Radical Cystectomy

    Not yet reported Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 280 participants Est. completion 2012-01 20 sites
    Other conditions: Postoperative Ileus
    View official trial listing →
  • Completed NCT NCT00709228

    Study of Patients With Chronic Hepatitis C Infected With HCV LVL G1 and Effect of Peg-Intron Plus Rebetol Treatment (Study P04793)

    Merck Sharp & Dohme LLC 496 participants Est. completion 2008-11
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00717821

    A Study of Once Monthly Intravenous or Subcutaneous Mircera in Participants With Chronic Kidney Disease on Hemodialysis.

    Not yet reported Hoffmann-La Roche 421 participants Est. completion 2011-07 89 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT00723242

    The Role of Dendritic Cells in Hepatitis C Infection

    Not yet reported University College, London Est. completion 2004-12 1 site
    Other conditions: Chronic Hepatitis C Infection
    View official trial listing →
  • Completed NCT NCT00723645

    Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)

    Merck Sharp & Dohme LLC 279 participants Est. completion 2011-02
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Status unknown NCT NCT00746746

    A Phase II Study of an Anti-Tumor Immunotherapy Regimen Comprised of Pegylated Interferon-Alpha 2b and HyperAcute Melanoma Vaccine for Subjects With Advanced Melanoma

    Not yet reported Ochsner Health System 30 participants Est. completion 2011-06 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00753454

    Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

    Not yet reported UCB Pharma 168 participants Est. completion 2011-05 40 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00756977

    BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

    Not yet reported Braintree Laboratories 394 participants 12 sites
    Other conditions: Colon Cancer
    View official trial listing →
  • Status unknown NCT NCT00777673

    Preoperative Chemotherapy in Triple Negative Invasive Breast Cancer That Can be Removed by Surgery.

    Not yet reported University of Tennessee Cancer Institute 60 participants Est. completion 2013-10 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00791271

    Parallel Phase I/II Trial of Decitabine and Peg-Interferon in Melanoma: Phase I Portion

    Not yet reported M.D. Anderson Cancer Center 17 participants Est. completion 2015-05 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT00796354

    Constipation Associated With Irritable Bowel Syndrome (IBS-C)

    Not yet reported Norgine 210 participants Est. completion 2010-02 21 sites
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT00844285

    SECURE, the Cimzia ® Crohn's Disease Post-Marketing Registry

    UCB BIOSCIENCES, Inc. 3072 participants Est. completion 2020-08-21 197 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT00845663

    Comparison Bioequivalence Study: Pre-filled Syringe (Reference) Versus Auto-injection Device (Test)

    Not yet reported UCB Pharma 98 participants Est. completion 2008-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00846430

    Medical Treatment of "High-Risk" Neurofibromas

    Not yet reported Corewell Health West 9 participants Est. completion 2017-05 1 site Stand-alone
    Other conditions: Neurofibromatosis 1
    View official trial listing →
  • Completed NCT NCT00857272

    F38-27: An Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects

    Not yet reported Braintree Laboratories 308 participants 6 sites Stand-alone
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT00868985

    Effects of Oral PEG 3350 on Electrolyte Balance

    Not yet reported Norgine 114 participants 1 site Stand-alone
    Other conditions: Chronic Constipation
    View official trial listing →
  • Completed NCT NCT00880763

    A Study of Safety and Efficacy of Vaniprevir Administered With Pegylated-Interferon and Ribavirin in Japanese Participants With Chronic Hepatitis C Infection (7009-016)

    Not yet reported Merck Sharp & Dohme LLC 90 participants Est. completion 2012-02-23 Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT00889655

    A Trial Comparing Bowel Preparation and Patient Tolerability of Miralax Versus Golytely

    Not yet reported Oregon Health and Science University 432 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Colonoscopy
    View official trial listing →
  • Withdrawn NCT NCT00895882

    Study to Evaluate Different Regimens of Vaniprevir (MK7009) for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients (MK-7009-019)(WITHDRAWN)

    Not yet reported Merck Sharp & Dohme LLC Est. completion 2013-01 Stand-alone
    Other conditions: Chronic Genotype 1 Hepatitis C Virus Infection
    View official trial listing →
  • Completed NCT NCT00926614

    Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

    Not yet reported Brooke Army Medical Center 20 participants Est. completion 2011-12 1 site
    Other conditions: Hepatitis c
    View official trial listing →
  • Status unknown NCT NCT00931840

    A Study of EZN-2208 Administered With or Without Cetuximab in Patients With Metastatic Colorectal Carcinoma

    Not yet reported Enzon Pharmaceuticals, Inc. 220 participants Est. completion 2012-01 60 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00932971

    HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis

    Not yet reported HepNet Study House, German Liverfoundation 70 participants Est. completion 2017-08-02 10 sites
    Other conditions: Hepatitis D
    View official trial listing →
  • Completed NCT NCT00938951

    Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.

    Not yet reported Alcon Research 16 participants
    Other conditions: Dry Eye Symptoms, Visual Performance
    View official trial listing →
  • Terminated NCT NCT00977054

    Double Filtration Plasmapheresis for Hepatitis C Virus (HCV) Genotype 1 Patients With High Viral Load

    Not yet reported National Taiwan University Hospital 59 participants Est. completion 2012-12 6 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00991289

    Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 68 participants Est. completion 2012-01 18 sites Stand-alone
    Other conditions: HIV Infection, Hepatitis C Infection
    View official trial listing →
  • Completed NCT NCT00993668

    Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

    Not yet reported UCB Pharma 224 participants Est. completion 2011-02 41 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01010282

    Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects

    Not yet reported Allergan 288 participants Est. completion 2010-04 1 site
    Other conditions: Dry Eye Syndrome
    View official trial listing →
  • Status unknown NCT NCT01024894

    Dose Escalation Study of Interleukin-7 (IL-7) and Bitherapy in Asiatic HCV Patients Resistant to Bitherapy

    Not yet reported, Not yet reported Cytheris SA 15 participants Est. completion 2012-12 4 sites
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT01038947

    Safety and Efficacy Study of Intramuscular Uricase-PEG 20

    Not yet reported EnzymeRx 28 participants Est. completion 2010-05 2 sites Stand-alone
    Other conditions: Gout, Hyperuricemia
    View official trial listing →
  • Terminated NCT NCT01039103

    Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)

    Not yet reported Lakefront Biotherapeutics NV 15 participants Est. completion 2011-11 8 sites Stand-alone
    Other conditions: Acute Exacerbation of Remitting Relapsing Multiple Sclerosis, Clinically Isolated Syndrome
    View official trial listing →
  • Withdrawn NCT NCT01044394

    Same-day, Reduced Volume Bowel Preparation

    Not yet reported Boston Medical Center Est. completion 2011-06 1 site Stand-alone
    Other conditions: Bowel Preparation
    View official trial listing →
  • Completed NCT NCT01087788

    Certolizumab Pegol in Subjects With Adult Onset Active and Progressive Psoriatic Arthritis

    Not yet reported UCB BIOSCIENCES GmbH 409 participants Est. completion 2015-08 92 sites
    Other conditions: Arthritis, Psoriatic
    View official trial listing →
  • Completed NCT NCT01094873

    Study of a Novel Therapeutic Vaccine for Hepatitis C Virus

    Not yet reported ReiThera Srl 35 participants Est. completion 2013-04 2 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01098201

    Certolizumab and Lower Extremity Lymph Flow in Rheumatoid Arthritis (RA)

    University of Rochester 5 participants Est. completion 2014-07 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01099124

    Study of M2ES With Paclitaxel/Carboplatin (TC Regimen) in Advanced Non Small Cell Lung Cancer (NSCLC)

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 25 participants Est. completion 2011-09 1 site
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT01119040

    Prospective Evaluation of NOTES (Natural Orifice Translumenal Endoscopic Surgery) PEG "Rescue"

    Not yet reported University Hospitals Cleveland Medical Center 1 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Malnutrition
    View official trial listing →
  • Completed NCT NCT01147341

    Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia

    Not yet reported Michael Schiff, MD 37 participants Est. completion 2012-01 12 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01156363

    A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia

    Not yet reported Hoffmann-La Roche 86 participants Est. completion 2013-01 3 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01169636

    Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 62 participants Est. completion 2017-05-17 1 site
    Other conditions: Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01170754

    Miralax (PEG 3350) vs. Golytely as Bowel Preparation for Screening Colonoscopy

    Not yet reported Temple University 136 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: Colon Cancer
    View official trial listing →
  • Completed NCT NCT01181570

    Efficacy and Safety of Adalimumab in Patients With Psoriasis and Obstructive Sleep Apnea

    Not yet reported Innovaderm Research Inc. 20 participants Est. completion 2011-09 1 site
    Other conditions: Psoriasis, Sleep Apnea, Obstructive
    View official trial listing →
  • Completed NCT NCT01183169

    Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

    Not yet reported Debiopharm International SA 459 participants Est. completion 2013-05 75 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01185028

    A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

    Not yet reported, Not yet reported National Institutes of Health Clinical Center (CC) 8 participants Est. completion 2011-10 4 sites Stand-alone
    Other conditions: Hepatitis C Infection, HIV Infection
    View official trial listing →
  • Terminated NCT NCT01186328

    EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL)

    Not yet reported Therapeutic Advances in Childhood Leukemia Consortium 6 participants Est. completion 2012-01-10 7 sites Stand-alone
    Other conditions: Lymphoblastic Leukemia, Acute, Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, T Cell, Leukemia, Lymphoblastic, Acute
    View official trial listing →
  • Completed NCT NCT01188772

    Sofosbuvir in Combination With Pegylated Interferon and Ribavirin and in Treatment-Naive Hepatitis C-infected Patients

    Not yet reported Gilead Sciences 147 participants Est. completion 2012-05 23 sites Stand-alone
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Terminated NCT NCT01189409

    Polyethylene Glycol (PEG) Versus Sennosides Study in Opioid-Induced Constipation in Cancer Patients

    Not yet reported British Columbia Cancer Agency 70 participants Est. completion 2018-10 1 site Stand-alone
    Other conditions: Constipation, Cancer
    View official trial listing →
  • Completed NCT NCT01190410

    Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol

    Not yet reported UCB Pharma 16 participants Est. completion 2017-11-27 10 sites
    Other conditions: Crohn's Disease
    View official trial listing →
  • Completed NCT NCT01195181

    Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.

    Not yet reported Azienda Ospedaliera di Padova 506 participants Est. completion 2010-08 1 site
    Other conditions: Hepatitis C Virus, Chronic Liver Disease, Viral Hepatitis, Therapeutic Uses, Antiviral Agents
    View official trial listing →
  • Completed NCT NCT01226446

    Efficacy of Vitamin D on Top of Pegylated Interferon and Ribavirin in Patients With Chronic Viral Hepatitis C Null-Responders

    Not yet reported French National Agency for Research on AIDS and Viral Hepatitis 32 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT01235598

    Magnetic Resonance Image Verified Early Response to Certolizumab Pegol in Subjects With Active Rheumatoid Arthritis (RA)

    Not yet reported UCB Pharma 41 participants Est. completion 2013-05 10 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01243281

    Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B

    Not yet reported Chulalongkorn University 126 participants Est. completion 2013-12 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT01251822

    Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic Constipation

    Not yet reported Norgine 240 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT01257204

    Study in Genotype 2 or 3 Patients With Chronic Hepatitis Virus Infection

    Not yet reported Bristol-Myers Squibb 196 participants Est. completion 2012-09 26 sites
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Terminated NCT NCT01258634

    A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

    Not yet reported University of Chicago 2 participants Est. completion 2011-11 1 site
    Obstructive sleep apnea Other conditions: Lung Metastases
    View official trial listing →
  • Completed NCT NCT01264367

    A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)

    Not yet reported Bukwang Pharmaceutical 60 participants Est. completion 2014-05 1 site
    Other conditions: HBeAg(+) Chronic Hepatitis B
    View official trial listing →
  • Terminated NCT NCT01266018

    Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer

    Not yet reported Ludwig Institute for Cancer Research 22 participants Est. completion 2014-01 8 sites Stand-alone
    Other conditions: Small Cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT01279967

    A Clinical Trial of ADI-PEG 20TM in Patients With Malignant Pleural Mesothelioma

    Not yet reported Barts & The London NHS Trust 70 participants Est. completion 2015-03 7 sites Stand-alone
    Other conditions: Malignant Pleural Mesothelioma
    View official trial listing →
  • Completed NCT NCT01295151

    SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.

    Not yet reported Julia Brown 122 participants Est. completion 2015-11 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01295697

    Study of EZN-2208 Pediatric Patients With Solid Tumors

    Not yet reported, Not yet reported Enzon Pharmaceuticals, Inc. 32 participants Est. completion 2013-01 4 sites
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT01296451

    Study of a New MVA Vaccine for Hepatitis C Virus

    Not yet reported ReiThera Srl 55 participants Est. completion 2016-01 3 sites Stand-alone
    Other conditions: Hepatitis C Infection
    View official trial listing →
  • Completed NCT NCT01318694

    Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants

    Not yet reported Debiopharm International SA 1081 participants Est. completion 2013-08 146 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01320059

    Study of 18F-Fluoro-PEG6-IPQA

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2016-04 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT01324284

    Comparative Study of Lubiprostone and PEG Preparation Versus Conventional PEG Preparation for Colonoscopy

    Not yet reported Asian Institute of Gastroenterology, India 442 participants Est. completion 2011-06 Stand-alone
    Other conditions: Colorectal Carcinoma
    View official trial listing →
  • Completed NCT NCT01355289

    Chronic Hepatitis C Virus Related Thrombocytopenia to Evaluate the Effects of E5501

    Not yet reported Eisai Inc. 65 participants Est. completion 2014-05 2 sites Stand-alone
    Other conditions: Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT01355705

    Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma

    Not yet reported, Not yet reported Michaela Liedtke 14 participants Est. completion 2017-07 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01356407

    Investigation of PICOPREP and PEG-ELS for Bowel Preparation for Colonoscopy

    Not yet reported Ferring Pharmaceuticals 300 participants Est. completion 2011-07 7 sites
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT01370642

    Vaniprevir Administered With Pegylated-interferon and Ribavirin in Japanese Treatment-Naïve Chronic Hepatitis C Participants (MK-7009-043)

    Not yet reported Merck Sharp & Dohme LLC 294 participants Est. completion 2014-03-17 Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT01389323

    BMS-790052 (Daclatasvir) Plus Peg-Interferon Alfa-2a and Ribavirin in Treatment-Naive Black/African-Americans, Latinos and White/Caucasians With Hepatitis C

    Not yet reported Bristol-Myers Squibb 448 participants Est. completion 2014-01 36 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01422824

    An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) as Maintenance Treatment in Patients With Chronic Renal Anemia on Haemodialysis

    Hoffmann-La Roche 185 participants Est. completion 2014-01 6 sites
    Other conditions: Anemia, Kidney Disease, Chronic
    View official trial listing →
  • Completed NCT NCT01427296

    Safety and Efficacy of OsmoPrep® Tablets Versus HalfLytely® and Bisacodyl Tablet Bowel Prep Kit for Colon Cleansing

    Not yet reported Bausch Health Americas, Inc. 2154 participants Est. completion 2014-12-09 18 sites
    Other conditions: Colon Cleansing
    View official trial listing →
  • Completed NCT NCT01434277

    Safety Evaluation of a New Preservative in a Lubricating Eye Drop

    Not yet reported Johnson & Johnson Consumer and Personal Products Worldwide 44 participants Est. completion 2011-04 1 site
    Other conditions: Dry Eye Syndromes
    View official trial listing →
  • Terminated NCT NCT01440595

    Grazoprevir (MK-5172) With Peg-Interferon and Ribavirin in Participants With Chronic Genotype 2 or 3 Hepatitis C (MK-5172-012)

    Not yet reported Merck Sharp & Dohme LLC 5 participants Est. completion 2012-05-01 Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT01442311

    Directly Observed Hepatitis C Treatment in Methadone Clinics

    Not yet reported Albert Einstein College of Medicine 80 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Hepatitis C, Medication Adherence
    View official trial listing →
  • Completed NCT NCT01443364

    Open Label Study to Assess the Predictability of Early Response to Certolizumab Pegol in Patients With Rheumatoid Arthritis

    Not yet reported UCB Italy s.p.a. 132 participants Est. completion 2015-05 18 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01446250

    Alisporivir (Deb025) and Boceprevir Triple Therapies in African American Participants Not Previously Treated for Chronic Hepatitis C Genotype 1

    Not yet reported Debiopharm International SA 8 participants Est. completion 2013-05 2 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01454388

    A Trial Comparing Breakfast Versus no Breakfast Prior to Colonoscopy

    Not yet reported Queen's University 496 participants 1 site
    Other conditions: Clinically Indicated Colonoscopy
    View official trial listing →
  • Completed NCT NCT01467986

    Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma

    Not yet reported University of Regensburg 130 participants Est. completion 2020-09-30 1 site
    Other conditions: Neuroblastoma Recurrent
    View official trial listing →
  • Completed NCT NCT01469715

    A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM)

    Not yet reported University of Virginia 16 participants Est. completion 2012-07 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Available NCT NCT01487044

    A Single-Center Trial of High Frequency Pegaptanib for Rapid Restoration of VEGF Levels in Diabetic Retinal Edema

    Retina Institute of Hawaii 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01489371

    EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

    Not yet reported Gynecologic Oncology Group 16 participants Est. completion 2018-01-27 7 sites Stand-alone
    Other conditions: Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma
    View official trial listing →
  • Completed NCT NCT01496807

    Yervoy With Sylatron Unresectable Stage 3 or 4 Melanoma

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 31 participants Est. completion 2016-08-29 1 site
    Other conditions: Melanoma
    View official trial listing →
  • Completed NCT NCT01498068

    Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C

    Not yet reported Janssen-Cilag International NV 36 participants Est. completion 2013-03 5 sites Stand-alone
    Other conditions: Genotype 1 Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT01500278

    Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

    Not yet reported UCB Pharma SA 915 participants Est. completion 2016-01 175 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01502696

    Adjuvant PEG Intron in Ulcerated Melanoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 1200 participants Est. completion 2019-04 58 sites Stand-alone
    Other conditions: Ulcerated Melanomas
    View official trial listing →
  • Completed NCT NCT01513811

    Itopride as an Adjuvant for Bowel Preparation in Patients With Chronic Constipation is Effective

    Not yet reported Shanghai Jiao Tong University School of Medicine 115 participants Est. completion 2011-12 1 site
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT01516736

    Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim

    Not yet reported Sandoz 308 participants Est. completion 2013-12 53 sites
    Other conditions: Chemotherapy-induced Neutropenia, Breast Cancer
    View official trial listing →
  • Completed NCT NCT01519921

    A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B.

    Not yet reported Hoffmann-La Roche 150 participants Est. completion 2008-06 7 sites Stand-alone
    Other conditions: Hepatitis B, Chronic
    View official trial listing →
  • Completed NCT NCT01522820

    Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

    Not yet reported Roswell Park Cancer Institute 18 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Estrogen Receptor Negative, Estrogen Receptor Positive, Glioblastoma, Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Metastatic Renal Cell Cancer, Recurrent Adult Brain Neoplasm, Recurrent Bladder Carcinoma, Recurrent Breast Carcinoma, Recurrent Colorectal Carcinoma, Recurrent Esophageal Carcinoma, Recurrent Gastric Carcinoma, Recurrent Hepatocellular Carcinoma, Recurrent Lung Carcinoma, Recurrent Melanoma, Recurrent Ovarian Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Cell Carcinoma, Recurrent Uterine Corpus Carcinoma, Resectable Hepatocellular Carcinoma, Sarcoma, Stage IA Breast Cancer, Stage IA Ovarian Cancer, Stage IA Uterine Corpus Cancer, Stage IB Breast Cancer, Stage IB Ovarian Cancer, Stage IB Uterine Corpus Cancer, Stage IC Ovarian Cancer, Stage II Uterine Corpus Cancer, Stage IIA Breast Cancer, Stage IIA Lung Carcinoma, Stage IIA Ovarian Cancer, Stage IIB Breast Cancer, Stage IIB Esophageal Cancer, Stage IIB Lung Carcinoma, Stage IIB Ovarian Cancer, Stage IIB Skin Melanoma, Stage IIC Ovarian Cancer, Stage IIC Skin Melanoma, Stage IIIA Breast Cancer, Stage IIIA Esophageal Cancer, Stage IIIA Lung Carcinoma, Stage IIIA Ovarian Cancer, Stage IIIA Skin Melanoma, Stage IIIA Uterine Corpus Cancer, Stage IIIB Breast Cancer, Stage IIIB Esophageal Cancer, Stage IIIB Ovarian Cancer, Stage IIIB Skin Melanoma, Stage IIIB Uterine Corpus Cancer, Stage IIIC Breast Cancer, Stage IIIC Esophageal Cancer, Stage IIIC Ovarian Cancer, Stage IIIC Skin Melanoma, Stage IIIC Uterine Corpus Cancer, Stage IV Bladder Urothelial Carcinoma, Stage IV Esophageal Cancer, Stage IV Ovarian Cancer, Stage IV Prostate Cancer, Stage IV Skin Melanoma, Stage IVA Uterine Corpus Cancer, Stage IVB Uterine Corpus Cancer
    View official trial listing →
  • Completed NCT NCT01523977

    Everolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL

    Not yet reported Dana-Farber Cancer Institute 22 participants Est. completion 2018-11 8 sites
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT01524679

    Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen

    Not yet reported Johannes Gutenberg University Mainz 170 participants Est. completion 2017-08-28 24 sites
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT01533090

    Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy

    Not yet reported Catholic University of the Sacred Heart 162 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Colonic Polyps, Cancer Colon, Inflammatory Bowel Disease
    View official trial listing →
  • Completed NCT NCT01563744

    EGD-assisted Bowel Preparation for Colonoscopy

    Not yet reported Rockford Gastroenterology Associates 82 participants Est. completion 2012-03 2 sites
    Other conditions: Esophagoscopy Techniques, Colonoscopy
    View official trial listing →
  • Status unknown NCT NCT01576354

    Characterization of the Effects of Prolonged-release Fampridine on Ambulatory Function in Patients With Multiple Sclerosis

    Not yet reported University of Zurich 70 participants Est. completion 2017-04 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01589094

    Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 51 participants Est. completion 2018-08 8 sites Stand-alone
    Other conditions: Bladder Cancer
    View official trial listing →
  • Completed NCT NCT01593124

    Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation

    Not yet reported CONRAD 20 participants Est. completion 2013-04 1 site
    Other conditions: Vaginal Inflammation, Vaginal Infections
    View official trial listing →
  • Status unknown NCT NCT01599130

    Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss

    Not yet reported Sun Yat-sen University 60 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Hepatitis B
    View official trial listing →
  • Completed NCT NCT01603654

    Sodium Picosulphate/Magnesium Citrate and Low-volume PEG -Ascorbic Acid as Preparation for Colonoscopy

    Not yet reported ASST Fatebenefratelli Sacco 300 participants Est. completion 2011-09 3 sites
    Other conditions: Colon Cleansing for Colonoscopy
    View official trial listing →
  • Completed NCT NCT01605513

    Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease

    Not yet reported, Not yet reported The First Hospital of Jilin University 80 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT01607099

    Sodium Picosulfate Plus Magnesium Citrate Versus Macrogol 4000 in the Bowel Cleansing Procedure: a Comparison of Efficiency and Compatibility

    Not yet reported Technical University of Munich 220 participants Est. completion 2014-11 1 site
    Other conditions: Laxative Compatibility
    View official trial listing →
  • Completed NCT NCT01610310

    Peginterferon Beta-1a (BIIB017) Autoinjector Pharmacokinetic Study in Healthy Volunteers

    Not yet reported Biogen 55 participants Est. completion 2012-10 1 site
    Other conditions: Healthy, Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT01639885

    Chemo-immunotherapy (Gemcitabine, Interferon-alpha 2b and p53 SLP) in Patients With Platinum-resistant Ovarian Cancer

    Not yet reported, Not yet reported Leiden University Medical Center 15 participants 1 site Stand-alone
    Other conditions: Recurrent Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT01650038

    Transplantation of Faeces in Ulcerative Colitis; Restoring Nature's Homeostasis

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 50 participants Est. completion 2014-12 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Status unknown NCT NCT01665001

    Personalized Therapy of Precursor Lymphoid Neoplasms

    Not yet reported Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice 200 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Precursor Lymphoid Neoplasms
    View official trial listing →
  • Completed NCT NCT01674855

    Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia

    Not yet reported Dong-A ST Co., Ltd. 74 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Chemotherapy Induced Neutropenia
    View official trial listing →
  • Completed NCT NCT01675739

    Effectiveness of Fixed PC Interval Using SMS for Afternoon Colonoscopy

    Not yet reported Inje University 280 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Effectiveness of SMS to Fix PC Interval
    View official trial listing →
  • Completed NCT NCT01677767

    An Observational Study of Mircera (Methoxy Polyethylene Glycol-Epoetin Beta) in Chronic Kidney Disease Patients on Dialysis With Renal Anemia

    Hoffmann-La Roche 127 participants Est. completion 2013-09-30 7 sites
    Other conditions: Anemia
    View official trial listing →
  • Status unknown NCT NCT01683786

    36 vs 48 Wks Peg-Intron Plus Ribavirin for HCV Patients Without Rapid Virologic Response But Without HCV RNA at wk 8

    Not yet reported Chang Gung Memorial Hospital 60 participants Est. completion 2014-12 5 sites
    Other conditions: Hepatitis C Infection
    View official trial listing →
  • Status unknown NCT NCT01687530

    Evaluation of the Safety and Efficacy of a Guided Bone Regeneration Membrane for the Treatment of Femoral Fractures

    Not yet reported, Not yet reported RegeneCure, Ltd. 48 participants 2 sites
    Other conditions: Proximal (Subtrochanteric)Femoral Fractures, Distal Femoral Fractures
    View official trial listing →
  • Completed NCT NCT01699100

    Reduction of Plantar Pressure in Neuropathic Diabetic Foot Patients Using Insoles With Removable Pegs Design

    Not yet reported Taichung Veterans General Hospital 26 participants Est. completion 2012-05 Stand-alone
    Other conditions: Foot Ulcer, Diabetic
    View official trial listing →
  • Completed NCT NCT01701336

    Study of a Novel Therapeutic Vaccine Against Hepatitis C Using Ad6NSmut and MVA-NSmut in Chronically Infected Patients

    Not yet reported ReiThera Srl 9 participants Est. completion 2013-02 2 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT01731301

    A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)

    Not yet reported Liver Institute of Virginia 20 participants Est. completion 2015-01 1 site
    Other conditions: Chronic Hepatitis C, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01745835

    Comparison Between 2L Coolprep® and Combination of 1L Coolprep® and Bisacodyl as Bowel Preparation

    Not yet reported Seoul National University Hospital 196 participants Est. completion 2014-01-31 1 site Stand-alone
    Other conditions: Healthy Person, Bowel Preparation Before Colonoscopy
    View official trial listing →
  • Completed NCT NCT01747655

    A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study

    AbbVie (prior sponsor, Abbott) 64 participants Est. completion 2015-07
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01756612

    A Study to Assess Hemoglobin Level Depending on the Comorbidity Index in Chronic Kidney Disease (CKD) Participants Not in Dialysis Treated With Methoxy Polyethylene Glycol-Epoetin Beta (COMETE)

    Hoffmann-La Roche 551 participants Est. completion 2015-03-25 108 sites
    Chronic kidney disease
    View official trial listing →
  • Withdrawn NCT NCT01770223

    A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)

    Not yet reported Merck Sharp & Dohme LLC Est. completion 2015-12
    Other conditions: Hepatitis C
    View official trial listing →
  • Status unknown NCT NCT01797770

    Trial on Mechanical Bowel Preparation in Laparoscopic Colorectal Surgery

    PVS Memorial Hospital 90 participants Est. completion 2014-02 1 site
    Other conditions: Rectal Cancer, Colon Cancer
    View official trial listing →
  • Completed NCT NCT01819727

    An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165

    Not yet reported BioMarin Pharmaceutical 261 participants Est. completion 2015-11-25 31 sites
    Other conditions: Phenylketonuria
    View official trial listing →
  • Completed NCT NCT01834742

    Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects

    Not yet reported Norgine 161 participants Est. completion 2011-12 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01838408

    Evaluation of Proposed EZ2go Complete Bowel Cleansing System

    Not yet reported Borland-Groover Clinic 185 participants Est. completion 2014-06 1 site Stand-alone
    Other conditions: Screening Colonoscopy, Surveillance Colonoscopy, Colonoscopy
    View official trial listing →
  • Completed NCT NCT01838772

    HCV Treatment in HIV Co-Infected Patients in Asia

    Not yet reported amfAR, The Foundation for AIDS Research 188 participants Est. completion 2016-09 4 sites
    Other conditions: Hepatitis C, HIV
    View official trial listing →
  • Completed NCT NCT01872442

    Combination of Dasatinib and Peg-Interferon Alpha 2b in First Line for Chronic Myeloid Leukemia in Chronic Phase

    Not yet reported Poitiers University Hospital Est. completion 2018-10-31 Stand-alone
    Other conditions: Chronic Phase of Chronic Myeloid Leukemia
    View official trial listing →
  • Terminated NCT NCT01878708

    A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma

    Not yet reported Dana-Farber Cancer Institute 2 participants Est. completion 2017-02 2 sites Stand-alone
    Other conditions: T-Cell Lymphoma, Relapsed T-Cell Lymphoma, Refractory T-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01889862

    Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU

    Not yet reported BioMarin Pharmaceutical 215 participants Est. completion 2019-02-05 29 sites
    Other conditions: Phenylketonuria (PKU)
    View official trial listing →
  • Status unknown NCT NCT01893060

    Umbilical Cord Care for the Prevention of Colonization

    Not yet reported University of Virginia 100 participants Est. completion 2014-07 1 site
    Other conditions: Line Insertion Site, Central Line-associated Bloodstream Infection (CLABSI)
    View official trial listing →
  • Completed NCT NCT01898091

    Herbal Mouthrinse for Oral Mucositis Study

    Not yet reported Medical University of South Carolina 50 participants Est. completion 2015-06 1 site
    Other conditions: Oral Mucositis
    View official trial listing →
  • Completed NCT NCT01909557

    Acetyl-L-Carnitine Supplementation During HCV Therapy With Peg IFN-α2b Plus Ribavirin: Effect on Work Performance.

    Not yet reported University of Catania 62 participants Est. completion 2011-12 1 site
    Other conditions: Quality of Life, Daily Activity, Fatigue
    View official trial listing →
  • Completed NCT NCT01919255

    Evaluation of PICOLIGHT Plus COOLPREP, PICOLIGHT Plus CLICOLON for Bowel Preparation

    Not yet reported National Cancer Center, Korea 236 participants Est. completion 2014-10 1 site
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT01920737

    A Novel "Pediatric-Inspired" Regimen With Reduced Myelosuppressive Drugs for Adults (Aged 18-60) With Newly Diagnosed Ph Negative Acute Lymphoblastic Leukemia

    Not yet reported Memorial Sloan Kettering Cancer Center 39 participants Est. completion 2027-08 3 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT01933906

    Addition of P1101 to Imatinib Treatment in Patients With Chronic Phase Chronic Myeloid Leukaemia Not Achieving a Complete Molecular Response

    Not yet reported Arbeitsgemeinschaft medikamentoese Tumortherapie 12 participants Est. completion 2018-11-14 4 sites
    Other conditions: Chronic Phase Chronic Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01935817

    Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV

    Not yet reported University of Catania 64 participants Est. completion 2012-12 1 site
    Other conditions: Liver Fibrosis
    View official trial listing →
  • Completed NCT NCT01937728

    Tailored Regimens of PEGASYS® and Ribavirin for Genotype 1 Chronic Hepatitis C Patients Trial (TARGET-1)

    Not yet reported Kaohsiung Medical University Chung-Ho Memorial Hospital 542 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01940484

    An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Stage V Chronic Kidney Disease Participants on Hemodialysis

    Hoffmann-La Roche 98 participants Est. completion 2012-07-31 10 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01962441

    SOF (Sovaldi®) +RBV for 16 or 24 Weeks and SOF+RBV+Peg-IFN for 12 Weeks in Adults With Genotype 2 or 3 Chronic HCV Infection

    Not yet reported Gilead Sciences 601 participants Est. completion 2016-07-07 78 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Withdrawn NCT NCT01973504

    Phase 2c Dose Comparison Study of MP4OX in Trauma

    Not yet reported Sangart Est. completion 2016-03 31 sites
    Other conditions: Trauma, Hemorrhagic Shock, Lactic Acidosis
    View official trial listing →
  • Completed NCT NCT01974271

    An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)

    Hoffmann-La Roche 661 participants Est. completion 2015-04 76 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT01984008

    A Study of the Efficacy and Safety of Bowklean and Klean-Prep With Dulcolax for the Bowel Preparation Prior Colonoscopy

    Not yet reported Universal Integrated Corp. 631 participants Est. completion 2014-06-17 1 site
    Other conditions: Bowel Preparation Before Colonoscopy
    View official trial listing →
  • Completed NCT NCT01997892

    TRANSFORM - Observational Cohort Study of Darbepoetin Alfa Use in European Union (EU) Hemodialysis Patients Switched From PEG Epoetin Beta

    Amgen 1027 participants Est. completion 2013-07 32 sites
    Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT02006745

    Open Label Trial of PEG-IFN, RBV & TVR vs. PEG-IFN & RBV Alone in Tx of HCV-1 in HIV-1 Co-infected Patients (CHAT)

    Not yet reported St Stephens Aids Trust 20 participants Est. completion 2016-02 1 site
    Other conditions: HIV
    View official trial listing →
  • Completed NCT NCT02009202

    Preparation Prior to Colonoscopy in Children

    Not yet reported Skane University Hospital 71 participants Est. completion 2014-06 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT02009449

    A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors

    Not yet reported Eli Lilly and Company 353 participants Est. completion 2023-07-22 10 sites
    Other conditions: Melanoma, Prostate Cancer, Ovarian Cancer, Renal Cell Carcinoma, Colorectal Carcinoma, Pancreatic Carcinoma, Non-small Cell Lung Carcinoma, Solid Tumors, Breast Cancer
    View official trial listing →
  • Completed NCT NCT02019602

    A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta

    Not yet reported UCB BIOSCIENCES, Inc. 37 participants Est. completion 2016-11 8 sites
    Other conditions: Axial Spondyloarthritis (AxSpA), Non-radiographic Evidence-AxSpA, Ankylosing Spondylitis, Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02021643

    Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection

    Not yet reported Gilead Sciences 687 participants Est. completion 2016-11-03 35 sites Stand-alone
    Other conditions: Chronic HCV Infection
    View official trial listing →
  • Completed NCT NCT02042391

    Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy

    Not yet reported Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH 60 participants Est. completion 2022-07-13 18 sites Stand-alone
    Other conditions: Posttransplant Lymphoproliferative Disorder
    View official trial listing →
  • Completed NCT NCT02044653

    Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

    Not yet reported Genexine, Inc. 257 participants Est. completion 2017-04-20 5 sites
    Chronic kidney disease Other conditions: Anemia
    View official trial listing →
  • Completed NCT NCT02073552

    Colon Cleansing Quality of Polyethylene Glycol Compared With Polyethylene Glycol Plus Ascorbic Acid.

    Not yet reported Fundación Canaria Rafael Clavijo para la Investigación Biomédica 472 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Colonoscopy Preparation
    View official trial listing →
  • Completed NCT NCT02078427

    ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

    Baxalta now part of Shire 951 participants Est. completion 2024-01-16 110 sites
    Other conditions: Hemophilia A
    View official trial listing →
  • Completed NCT NCT02101580

    Ph 1B Trial With ADI-PEG 20 Plus Nab-Paclitaxel and Gemcitabine in Subjects With Pancreatic Cancer

    Not yet reported Polaris Group 21 participants Est. completion 2017-10-06 1 site Stand-alone
    Other conditions: Advanced Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT02102022

    Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

    Not yet reported, Not yet reported Polaris Group 140 participants Est. completion 2020-02 35 sites Stand-alone
    Other conditions: Advanced Gastrointestinal (GI) Malignancies, Hepatocellular Carcinoma, Gastric Cancer, Colorectal Cancer
    View official trial listing →
  • Terminated NCT NCT02119000

    Comparison of Two Types of Bowel Preparation for Inpatient Colonoscopy

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 82 participants Est. completion 2020-01 2 sites Stand-alone
    Other conditions: Hospitalized Patients
    View official trial listing →
  • Completed NCT NCT02202980

    Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection

    Not yet reported Gilead Sciences 273 participants Est. completion 2016-05-09 2 sites Stand-alone
    Other conditions: Chronic Hepatitis C
    View official trial listing →
  • Completed NCT NCT02215954

    A Phase III Study With FE 999169 Versus Niflec for Colon Cleansing

    Not yet reported Ferring Pharmaceuticals 637 participants Est. completion 2014-12 4 sites
    Other conditions: Colon Cleansing in Preparation for Colonoscopy
    View official trial listing →
  • Completed NCT NCT02228616

    Efficacy and Safety of Prucalopride in Combination With Polyethylene Glycol or Lactulose in Women With Chronic Constipation

    Not yet reported Xian-Janssen Pharmaceutical Ltd. 280 participants Est. completion 2016-09-28 9 sites Stand-alone
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT02232113

    Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients

    Not yet reported Taipei Veterans General Hospital, Taiwan 67 participants Est. completion 2013-01 1 site
    Other conditions: Anemia, Inflammation, Malnutrition
    View official trial listing →
  • Completed NCT NCT02238080

    An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Chronic Kidney Disease Participants on Dialysis

    Hoffmann-La Roche 197 participants Est. completion 2012-06 18 sites
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02253953

    Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 62 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02254538

    A Safety, Tolerability and Preliminary Pharmacokinetics of BILR 355 BS Single-rising Dose Study in Healthy Male Volunteers

    Not yet reported Boehringer Ingelheim 54 participants Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02256787

    Safety, Tolerance, and Pharmacokinetics of Single Rising Oral Doses of BILB 1941 ZW Solution in Healthy Male Subjects, Followed With Bioavailability Comparison of BILB 1941 ZW Tablet and Solution Formulation Administered With or Without Food

    Not yet reported Boehringer Ingelheim 56 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02263079

    A Study of Pegylated Interferon Alfa-2A in Combination With Lamivudine or Entecavir Compared With Untreated Control Group in Children With Hepatitis B Envelope Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB) in the Immune-Tolerant Phase

    Not yet reported Hoffmann-La Roche 62 participants Est. completion 2020-01-29 25 sites Stand-alone
    Other conditions: Pediatric Immuno-Tolerant Chronic Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT02279134

    Phase II/III Study Compare Adjuvant Chemoradiotherapy, Radiotherapy and Surgery Alone for Esophageal Carcinoma

    Not yet reported, Not yet reported Zefen Xiao 360 participants Est. completion 2024-12 1 site
    Other conditions: Esophageal Neoplasms, Esophageal Cancer
    View official trial listing →
  • Completed NCT NCT02285101

    Recombinant Human Arginase 1 (rhArg1) in Patients With Advanced Arginine Auxotrophic Solid Tumors

    Not yet reported Bio-Cancer Treatment International Limited 23 participants Est. completion 2019-02 2 sites Stand-alone
    Other conditions: Melanoma, Prostate Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT02289365

    Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients

    Not yet reported Joben Bio-Medical Co., Ltd. 120 participants Est. completion 2016-12 3 sites Stand-alone
    Other conditions: Radiodermatitis
    View official trial listing →
  • Completed NCT NCT02290093

    Bowel Preparation for Colonoscopy in the Elderly

    Not yet reported Kyunghee University Medical Center 230 participants Est. completion 2015-12 3 sites Stand-alone
    Other conditions: Bowel Preparation, Colonoscopy
    View official trial listing →
  • Withdrawn NCT NCT02290626

    Elemental Diets vs. Semi-solid Diets on Gastric Excretion and Gastroesophageal Regurgitation

    Not yet reported Showa Inan General Hospital Est. completion 2016-03 1 site Stand-alone
    Other conditions: Gastro-oesophageal Reflux
    View official trial listing →
  • Terminated NCT NCT02317549

    Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148

    Not yet reported Leading BioSciences, Inc 8 participants Est. completion 2016-03 34 sites Stand-alone
    Other conditions: Septic Shock
    View official trial listing →
  • Completed NCT NCT02328755

    Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 37 participants Est. completion 2019-03-25 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT02349620

    Effect of Platelet-rich Factor on Implant Stability and Bone Resorption in the Lower Posterior Mandible

    Not yet reported Reza Tabrizi 30 participants Est. completion 2015-10 1 site
    Other conditions: Osseointegrated Dental Implantation
    View official trial listing →
  • Completed NCT NCT02353832

    Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer

    Not yet reported University of Texas Southwestern Medical Center 44 participants Est. completion 2021-01-05 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02359825

    Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

    Not yet reported Vanderbilt University Medical Center 45 participants Est. completion 2026-05-21 1 site Stand-alone
    Other conditions: Peripheral Nerve Injury
    View official trial listing →
  • Status unknown NCT NCT02362490

    Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues

    Not yet reported Beijing Ditan Hospital 200 participants Est. completion 2016-12 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT02365402

    Efficacies of Entecavir Add on HBeAg Negative Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment

    Not yet reported Beijing Ditan Hospital 180 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT02366208

    Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 116 participants Est. completion 2013-08 12 sites Stand-alone
    Other conditions: Hepatitis B, Chronic
    View official trial listing →
  • Completed NCT NCT02380248

    Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects

    Not yet reported Alcon Research 207 participants Est. completion 2016-06-01 1 site
    Other conditions: Dry Eye
    View official trial listing →
  • Status unknown NCT NCT02387684

    Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients

    Beijing Ditan Hospital 120 participants Est. completion 2016-12 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT02393859

    Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

    Not yet reported Amgen 111 participants Est. completion 2022-11-21 103 sites
    Other conditions: Leukemia, Acute Lymphoblastic
    View official trial listing →
  • Completed NCT NCT02415569

    Tailored Bowel Preparation According to Bristol Stool Form Scale

    Not yet reported Shandong University 700 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Bowel Cleansing Quality
    View official trial listing →
  • Terminated NCT NCT02419469

    Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

    Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2017-06-22 1 site Stand-alone
    Other conditions: Leukemia, Precursor-B Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02419534

    Pediatrics Anal Fissures Treatment With Polyethylene Glycol

    Not yet reported King Saud University 46 participants Est. completion 2016-11 1 site
    Other conditions: Fissure in Ano
    View official trial listing →
  • Completed NCT NCT02430181

    Lonafarnib With and Without Ritonavir in HDV (LOWR-1)

    Not yet reported EIT Pharma, Inc. 21 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Chronic Hepatitis D Infection
    View official trial listing →
  • Completed NCT NCT02457546

    The EVICEL® Neurosurgery Phase III Study

    Not yet reported Ethicon, Inc. 234 participants Est. completion 2017-10-12 26 sites
    Other conditions: Cerebrospinal Fluid Leak
    View official trial listing →
  • Status unknown NCT NCT02466698

    Intestinal Lavage for the Treatment of Severe C. Difficile Infections

    Not yet reported, Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20 participants Est. completion 2019-08 1 site Stand-alone
    Other conditions: Clostridium Difficile
    View official trial listing →
  • Status unknown NCT NCT02467790

    Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 24 participants Est. completion 2016-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02468570

    A Phase 3 Substudy to Evaluate Executive Function in Adults With PKU Who Are Participating in the Phase 3 Study, 165-302

    BioMarin Pharmaceutical 9 participants Est. completion 2017-02-01 4 sites
    Other conditions: Phenylketonuria
    View official trial listing →
  • Status unknown NCT NCT02477969

    Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 587 participants Est. completion 2017-06 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02479360

    Reliability of Functional Outcome Measures in Neurofibromatosis 1

    Guy's and St Thomas' NHS Foundation Trust 49 participants Est. completion 2015-09 1 site
    Other conditions: Neurofibromatosis 1, NF1
    View official trial listing →
  • Completed NCT NCT02481219

    Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure

    Not yet reported Medtronic - MITG 122 participants Est. completion 2016-02 6 sites Stand-alone
    Other conditions: Colorectal Cancer Screening
    View official trial listing →
  • Completed NCT NCT02511249

    Early Determinants of Multidimensional Outcome at School Age After Neonatal Arterial Ischemic Stroke

    Centre Hospitalier Universitaire de Saint Etienne 80 participants Est. completion 2013-11 5 sites
    Other conditions: Cerebral Infarction
    View official trial listing →
  • Completed NCT NCT02551198

    Comparison of Polyethylene Glycol With Ascorbic Acid and Oral Sulfate Solution for Bowel Preparation

    Not yet reported National Cancer Center, Korea 184 participants Est. completion 2017-09-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02587065

    Plegridy Satisfaction Study in Participants

    Not yet reported Biogen 193 participants Est. completion 2017-12-21 30 sites
    Other conditions: Relapsing-Remitting Multiple Sclerosis (RRMS)
    View official trial listing →
  • Completed NCT NCT02620189

    Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα

    Queen Mary University of London 60 participants Est. completion 2017-05-24 8 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT02631239

    MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma

    Not yet reported Ruijin Hospital 256 participants Est. completion 2022-07-17 1 site Stand-alone
    Other conditions: Extranodal NK/T-cell Lymphoma, Nasal Type
    View official trial listing →
  • Completed NCT NCT02641379

    A Study of Peginterferon Alfa-2a (Pegasys) When Administered in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC)

    Not yet reported Hoffmann-La Roche 737 participants Est. completion 2013-11 21 sites Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Completed NCT NCT02643316

    Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study

    Not yet reported The Cleveland Clinic 200 participants Est. completion 2019-08 1 site
    Other conditions: Colonoscopy
    View official trial listing →
  • Terminated NCT NCT02685111

    Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)

    Not yet reported Asan Medical Center 22 participants Est. completion 2017-12 1 site
    Other conditions: Breast Cancer, Neutropenia, Febrile Neutropenia
    View official trial listing →
  • Completed NCT NCT02731963

    Mechanical Bowel Preparation for Elective Colorectal Anastomosis

    Not yet reported Instituto Mexicano del Seguro Social 81 participants Est. completion 2016-02 1 site
    Other conditions: Anastomosis
    View official trial listing →
  • Completed NCT NCT02732639

    A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)

    Not yet reported Hoffmann-La Roche 31 participants Est. completion 2008-12 7 sites Stand-alone
    Other conditions: Hepatitis D, Chronic
    View official trial listing →
  • Completed NCT NCT02751411

    Effectiveness & Safety of Promelaxin® Microenemas Against Macrogol 4000 P.O. in Chronic Constipation in Children 6-48 Months

    Not yet reported Aboca Spa Societa' Agricola 158 participants Est. completion 2020-03-17 4 sites
    Other conditions: Chronic Functional Constipation
    View official trial listing →
  • Status unknown NCT NCT02761460

    The Efficacy and Safety of PEG-rhG-CSF in Preventing Chemotherapy-induced Neutropenia

    Not yet reported wang shusen 338 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02772250

    Bowel Preparation by Face-to-face Re-education on the Day of Colonoscopy for Outpatient: a RCT

    Not yet reported Shandong University 658 participants Est. completion 2016-10 1 site
    Other conditions: Bowel Preparation
    View official trial listing →
  • Status unknown NCT NCT02781493

    Efficacy of Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopy

    Not yet reported Shandong University 600 participants Est. completion 2017-03 1 site
    Other conditions: Prucalopride Plus Polyethylene Glycol in Bowel Preparation for Colonoscopyp
    View official trial listing →
  • Terminated NCT NCT02788240

    To Study the Influence of GCSF on Natural History of Acute On Chronic Liver Failure After the Acute Phase

    Not yet reported Institute of Liver and Biliary Sciences, India 14 participants Est. completion 2017-07-15 1 site Stand-alone
    Other conditions: Acute on Chronic Liver Failure
    View official trial listing →
  • Completed NCT NCT02791269

    A Study of Peginterferon Alfa-2a in Participants With Chronic Hepatitis B Virus (HBV) in an Expanded Access Program

    Not yet reported Hoffmann-La Roche 24 participants Est. completion 2008-07 6 sites
    Other conditions: Hepatitis B, Chronic
    View official trial listing →
  • Completed NCT NCT02819323

    A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

    Not yet reported Braintree Laboratories 91 participants Est. completion 2018-03-27 27 sites
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT02828358

    Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement

    Not yet reported National Cancer Institute (NCI) 78 participants Est. completion 2024-12-31 170 sites
    Other conditions: Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia
    View official trial listing →
  • Completed NCT NCT02879643

    Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy

    Not yet reported Therapeutic Advances in Childhood Leukemia Consortium 29 participants Est. completion 2024-12-31 35 sites Stand-alone
    Other conditions: ALL, Childhood, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Acute
    View official trial listing →
  • Status unknown NCT NCT02887573

    Free-residue Nutrients for the Bowel Preparation of Colon Capsule Endoscopy

    Not yet reported Kaichun Wu 62 participants Est. completion 2017-07 Stand-alone
    Other conditions: Colorectal Polyps
    View official trial listing →
  • Active, not recruiting NCT NCT02938520

    Study to Evaluate the Efficacy, Safety, and Tolerability of Long-acting Intramuscular Cabotegravir and Rilpivirine for Maintenance of Virologic Suppression Following Switch From an Integrase Inhibitor in HIV-1 Infected Therapy Naive Participants

    Not yet reported ViiV Healthcare 631 participants Est. completion 2029-12-31 108 sites Stand-alone
    Other conditions: HIV Infections
    View official trial listing →
  • Status unknown NCT NCT02976675

    Pegylated Somatropin (PEG Somatropin) in the Treatment of Children With Growth Hormone Deficiency

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 600 participants 24 sites Stand-alone
    Other conditions: Growth Hormone Deficiency
    View official trial listing →
  • Terminated NCT NCT02977286

    Naloxegol to Prevent Lower Gastrointestinal Paralysis in Critically Ill Adults Administered Opioids

    Not yet reported Tufts Medical Center 12 participants Est. completion 2019-10-09 1 site
    Other conditions: Constipation
    View official trial listing →
  • Terminated NCT NCT02983097

    Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

    Not yet reported, Not yet reported Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 34 participants Est. completion 2015-04-28 12 sites Stand-alone
    Other conditions: Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma Grade III (FL III°), Mantle Cell Lymphoma (MCL), Blastoid Variant, Burkitt Lymphoma (BL), Aggressive Marginal Zone Lymphoma (MZL)
    View official trial listing →
  • Status unknown NCT NCT03013556

    Study on an Optimal Antiviral Treatment in HBeAg Positive Chronic Hepatitis B Patients

    Not yet reported Ruijin Hospital 180 participants Est. completion 2021-12-31 8 sites Stand-alone
    Other conditions: Chronic Hepatitis
    View official trial listing →
  • Status unknown NCT NCT03106922

    A Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in Children

    Not yet reported Alfasigma S.p.A. 430 participants Est. completion 2020-07 9 sites
    Other conditions: Bowel Preparation Before Colonoscopy
    View official trial listing →
  • Completed NCT NCT03109951

    Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation

    Not yet reported Catholic Kwandong University 187 participants Est. completion 2019-12-31 1 site
    Type 2 diabetes Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT03141931

    The Effects of Dietary Supplementation With Omega-3 Fatty Acids on Symptoms of Dry Eye

    Not yet reported The University of New South Wales 119 participants Est. completion 2018-10-19 1 site
    Other conditions: Dry Eye
    View official trial listing →
  • Completed NCT NCT03146052

    Comparison Between Asymmetric And Standard Split-Dose Regimen For Bowel Preparation

    Not yet reported ASST Rhodense 81 participants Est. completion 2017-05-05 1 site Stand-alone
    Other conditions: Polyps, Colon Preparation
    View official trial listing →
  • Status unknown NCT NCT03166683

    Standard of Care Versus Hemopatch® During Liver Resection

    Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 284 participants Est. completion 2020-09
    Other conditions: Liver Cancer, Hemorrhage Liver, Bile Leak, Surgery, Tumor Liver
    View official trial listing →
  • Completed NCT NCT03202927

    Comparative Immunogenicity Study Comparing TPI-120 to Neulasta® in Healthy Adult Subjects

    Not yet reported Adello Biologics, LLC 102 participants Est. completion 2018-04-12 2 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Active, not recruiting NCT NCT03220022

    Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas

    Not yet reported National Cancer Institute (NCI) 46 participants Est. completion 2027-07-16 19 sites
    Other conditions: AIDS-Related Lymphoma, Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage III Diffuse Large B-Cell Lymphoma, Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03242369

    Comparison of the Effectiveness of Bowel Preparations Before Colonoscopy

    Not yet reported Military University Hospital, Prague 400 participants Est. completion 2019-03-31 1 site Stand-alone
    Other conditions: Colorectal Neoplasms
    View official trial listing →
  • Completed NCT NCT03247595

    Testing How Well Magnesium Citrate Capsules Work as Preparation for a Colonoscopy

    Not yet reported LifeBridge Health 62 participants Est. completion 2020-06-16 2 sites
    Other conditions: Colonoscopy
    View official trial listing →
  • Terminated NCT NCT03254732

    Study ADI-PEG 20 Plus Pembrolizumab in Advanced Solid Cancers

    Not yet reported Polaris Group 33 participants Est. completion 2020-02-25 1 site Stand-alone
    Other conditions: Advanced Solid Cancers
    View official trial listing →
  • Completed NCT NCT03279341

    Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects

    Not yet reported University Hospital, Gasthuisberg 10 participants Est. completion 2016-03 1 site
    Other conditions: Chronic Constipation
    View official trial listing →
  • Completed NCT NCT03298945

    Comparative Effectiveness of Split-Dose Colonoscopy Bowel Preparation Regimens

    Not yet reported VA Office of Research and Development 2239 participants Est. completion 2024-06-30 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT03315949

    Comparison of Bowel Cleansing Efficacy Between Same-day Dose Versus Split Dose

    Not yet reported Incheon St.Mary's Hospital 352 participants Est. completion 2018-02-28 1 site Stand-alone
    Other conditions: Unrecognized Condition
    View official trial listing →
  • Completed NCT NCT03332485

    Safety and Efficacy Study of an Edible Colonoscopy Preparation

    Not yet reported Sebela Pharmaceuticals Development LLC 60 participants Est. completion 2018-03-14 8 sites
    Other conditions: Colon Prep for Colonoscopy
    View official trial listing →
  • Completed NCT NCT03357471

    Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

    Not yet reported UCB Biopharma S.P.R.L. 70 participants Est. completion 2018-07-02 22 sites
    Other conditions: Moderate and Severe Active Rheumatoid Arthritis, Active Psoriatic Arthritis, Active Ankylosing Spondylitis, Moderately to Severely Active Crohn's Disease
    View official trial listing →
  • Completed NCT NCT03371979

    Pegzilarginase and Pembrolizumab for Extensive Disease Small Cell Lung Cancer

    Not yet reported, Not yet reported Aeglea Biotherapeutics 68 participants Est. completion 2021-01-01 22 sites
    Other conditions: Small-cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT03448770

    To Compare Efficacy and Safety of Lactulose Versus Polyethylene Glycol for Treatment of Overt Hepatic Encephalopathy in Cirrhotics.

    Not yet reported Institute of Liver and Biliary Sciences, India 110 participants Est. completion 2018-07-31 1 site Stand-alone
    Other conditions: Cirrhosis
    View official trial listing →
  • Completed NCT NCT03486821

    Ultra-hypofractionated Radiation in Prostate Cancer

    Not yet reported University of Kansas Medical Center 13 participants Est. completion 2026-03-02 1 site
    Other conditions: Early Stage Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03487536

    Nutritional Prognostic Factors in ALS

    University of Bari 47 participants Est. completion 2016-07-31 1 site
    Other conditions: Nutritional Deficiency, Neuro-Degenerative Disease, Gastrostomy
    View official trial listing →
  • Withdrawn NCT NCT03498222

    Study in Patients With Tumours Requiring Arginine to Assess ADI-PEG 20 With Atezolizumab, Pemetrexed and Carboplatin

    Not yet reported Queen Mary University of London Est. completion 2021-12-31
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT03511378

    Immunogenicity Assessment of Peg-filgrastim vs. Neulasta® as Adjunct to Chemotherapy in Patients With Breast Cancer

    Not yet reported Lupin Ltd. 138 participants Est. completion 2019-01-09 17 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT03531827

    Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatment

    Not yet reported National Cancer Institute (NCI) 4 participants Est. completion 2021-06-01 1 site Stand-alone
    Other conditions: Metastatic Castration Resistant Prostate Cancer, Prostate Neoplasms
    View official trial listing →
  • Terminated NCT NCT03547154

    Polyethylene Glycol Interferon Alfa-2b (PEG Intron) Versus Interferon Alfa-2b (INTRON^® A) in the Treatment of Newly Diagnosed Chronic Myelogenous Leukemia (CML) (C98026)

    Not yet reported, Not yet reported Merck Sharp & Dohme LLC 344 participants Est. completion 2001-02-20 Stand-alone
    Other conditions: Chronic Myelogenous Leukemia
    View official trial listing →
  • Status unknown NCT NCT03553238

    Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 70 participants Est. completion 2020-08-30 1 site Stand-alone
    Other conditions: Leukemia, Acute, Leukemia, T Cell, Leukemia, Lymphoblastic
    View official trial listing →
  • Status unknown NCT NCT03564704

    Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL

    Not yet reported, Not yet reported Nanfang Hospital, Southern Medical University 80 participants Est. completion 2021-05-30 1 site Stand-alone
    Other conditions: Leukemia, Leukemia, Acute, Adult Lymphoblastic Lymphoma, Leukemia, Lymphoblastic, Leukemia, T Cell, Adult Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Lymphoblastic Leukemia
    View official trial listing →
  • Status unknown NCT NCT03580135

    Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars

    Not yet reported Cairo University 28 participants Est. completion 2019-10-01 1 site
    Other conditions: Pulp Disease, Dental
    View official trial listing →
  • Status unknown NCT NCT03588715

    Peg-Interferon Alpha 2b Combined With Two Intravenous Broadly HIV-1 Neutralizing Antibodies 3BNC117 and 10-1074 (BEAT-2)

    Not yet reported Luis Montaner 15 participants Est. completion 2022-10-30 2 sites Stand-alone
    Other conditions: HIV, HIV/AIDS, HIV-1 Infection
    View official trial listing →
  • Completed NCT NCT03600714

    Treatment of Chronic Delta Hepatitis With Lonafarnib, Ritonavir and Lambda Interferon

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 26 participants Est. completion 2020-08-11 1 site Stand-alone
    Other conditions: Liver Disease, Hepatitis D
    View official trial listing →
  • Status unknown NCT NCT03610217

    Pragmatic Clinical Trials in Scleroderma

    Not yet reported University of West London 400 participants Est. completion 2021-10 1 site
    Other conditions: Scleroderma, Systemic, Sclerosis, Systemic
    View official trial listing →
  • Completed NCT NCT03645226

    Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease

    Chinese University of Hong Kong 441 participants Est. completion 2023-03-29 2 sites
    Other conditions: REM Sleep Behavior Disorder
    View official trial listing →
  • Completed NCT NCT03650725

    Evaluation of Information on Bowel Preparation for Morning Colonoscopy

    Harminder Singh 1000 participants Est. completion 2023-06-30 1 site
    Other conditions: Colonoscopy, Patient Compliance
    View official trial listing →
  • Completed NCT NCT03665766

    Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation

    Ain Shams University 126 participants Est. completion 2018-04-02
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT03701841

    Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis

    Anhui Provincial Hospital 1000 participants Est. completion 2020-12 1 site
    Other conditions: Chemotherapy-induced Neutropenia
    View official trial listing →
  • Completed NCT NCT03742232

    Study Comparing the Bowel Cleansing Efficacy of PLENVU® Versus SELG-ESSE® Using a 2-Day Split Dosing Regimen.

    Not yet reported Istituto Clinico Humanitas 399 participants Est. completion 2020-03-31 5 sites
    Other conditions: Colon Polyp, Colon Adenoma, Colon Lesion
    View official trial listing →
  • Withdrawn NCT NCT03747562

    Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients.

    Not yet reported University Hospital, Ghent Est. completion 2022-07-01 2 sites
    Other conditions: Head Neck Cancer, Radiation Neuropathy, Pain, Neuropathic
    View official trial listing →
  • Status unknown NCT NCT03753880

    Hemopatch for Prevention of Bile Leaks After Liver Resection

    Not yet reported Medical University of Vienna 71 participants Est. completion 2021-06 1 site
    Other conditions: Bile Leak
    View official trial listing →
  • Completed NCT NCT03765632

    Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

    Not yet reported, Not yet reported Great Ormond Street Hospital for Children NHS Foundation Trust 13 participants Est. completion 2022-09-28 1 site Stand-alone
    Other conditions: Severe Combined Immunodeficiency Due to ADA Deficiency
    View official trial listing →
  • Completed NCT NCT03787888

    Hyponatremia Due to Poly Ethylene Glycol (PEG)

    Tazeen Rasheed 151 participants Est. completion 2019-09-30 1 site
    Other conditions: Hyponatremia
    View official trial listing →
  • Terminated NCT NCT03808610

    Low-Intensity Chemotherapy and Venetoclax in Treating Patients With Relapsed or Refractory B- or T-Cell Acute Lymphoblastic Leukemia

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 53 participants Est. completion 2026-05-05 1 site
    Other conditions: Recurrent B Acute Lymphoblastic Leukemia, Recurrent T Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia, Refractory T Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT03864926

    Envarsus in Delayed Graft Function (E-DGF)

    Not yet reported University of Wisconsin, Madison 100 participants Est. completion 2022-07-22 1 site
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Status unknown NCT NCT03904303

    Test of a New Gel-based Colon Cleansing Agent Compared to Moviprep

    Not yet reported Zealand University Hospital 16 participants Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: Pharmacological Action
    View official trial listing →
  • Active, not recruiting NCT NCT03914625

    A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 6720 participants Est. completion 2027-09-30 228 sites
    Other conditions: B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma, Down Syndrome
    View official trial listing →
  • Completed NCT NCT03922880

    Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma

    Not yet reported Memorial Sloan Kettering Cancer Center 9 participants Est. completion 2023-01-20 1 site Stand-alone
    Other conditions: Uveal Melanoma
    View official trial listing →
  • Completed NCT NCT03936452

    Combined Treatment of Sintilimab, Peg-aspargase Plus Anlotinib in NK/T Cell Lymphoma

    Not yet reported Sun Yat-sen University 55 participants Est. completion 2021-12-30 1 site Stand-alone
    Other conditions: Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, Early Stage, Anlotinib, Peg-aspargase, Sintilimab, Phase Two, Open, Radiotherapy
    View official trial listing →
  • Status unknown NCT NCT04005118

    Human Intestinal Microbiome and Surgical Outcomes in Patients Undergoing Colorectal Cancer Surgery

    Assistance Publique - Hôpitaux de Paris 50 participants Est. completion 2020-04-01 1 site
    Other conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
    View official trial listing →
  • Completed NCT NCT04023669

    Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

    Not yet reported St. Jude Children's Research Hospital 21 participants Est. completion 2025-01-13 1 site Stand-alone
    Other conditions: Brain Tumor, Brain Tumor, Recurrent, Brain Tumor, Refractory, Brain Tumor, Pediatric, Medulloblastoma, Medulloblastoma Recurrent, Medulloblastoma, Non-WNT/Non-SHH, Medulloblastoma, Non-WNT/Non-SHH, Group 3, Medulloblastoma, Non-WNT/Non-SHH, Group 4, Brain Cancer, CNS Cancer, CNS Tumor, CNS Neoplasm
    View official trial listing →
  • Status unknown NCT NCT04033250

    Personalized Colonoscopy Preparation for Patients With Risk Factors for Inadequate Preparation

    Not yet reported Rambam Health Care Campus 600 participants Est. completion 2020-12 1 site
    Other conditions: Inadequate Preparation for Colonoscopy; Personalized Colonoscopy Preparation
    View official trial listing →
  • Active, not recruiting NCT NCT04035837

    The Clinical Cure Project of Chronic Hepatitis B in China

    Not yet reported Third Affiliated Hospital, Sun Yat-Sen University 30000 participants Est. completion 2026-06-30 1 site Stand-alone
    Other conditions: Hepatitis B, Chronic
    View official trial listing →
  • Status unknown NCT NCT04109105

    Study for the Efficacy and Security Analysis in the Protection of Ileocolic Anastomosis Conducted in Laparoscopic Right Hemicolectomy Because of Colon Cancer, Using a NHS-PEG Coated Collagen Patch.

    Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 30 participants Est. completion 2020-05-15 1 site
    Other conditions: Adenocarcinoma Colon
    View official trial listing →
  • Status unknown NCT NCT04189276

    Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

    Not yet reported Tasly Tianjin Biopharmaceutical Co., Ltd. 100 participants Est. completion 2021-12 3 sites
    Other conditions: Hepatitis B Virus (HBV)
    View official trial listing →
  • Completed NCT NCT04197869

    Does a Preoperative Bowel Regimen Change Time to First Bowel Movement After Robotic Sacral Colpopexy

    Not yet reported Northwell Health 71 participants Est. completion 2023-06-21 1 site Stand-alone
    Other conditions: Constipation, Post-Op Complication
    View official trial listing →
  • Completed NCT NCT04210427

    Cystic Fibrosis and Gut Dysmotility: The Effect of Polyethylene Glycol (PEG) on Intestinal Transit

    Not yet reported St. Louis University 3 participants Est. completion 2023-06-06 2 sites Stand-alone
    Other conditions: Cystic Fibrosis Gastrointestinal Disease
    View official trial listing →
  • Status unknown NCT NCT04438616

    Comparison of Patient Satisfaction and Primary Implant Stability Between Two Different Magnetic Attachment

    Not yet reported Cairo University 28 participants Est. completion 2021-04-30
    Other conditions: Edentulous Alveolar Ridge
    View official trial listing →
  • Withdrawn NCT NCT04440384

    Long Term Evaluation of Function and Quality of Life After Pollicisation

    Hospices Civils de Lyon Est. completion 2022-09-02 1 site
    Other conditions: Patients That Had Pollicization Surgery
    View official trial listing →
  • Terminated NCT NCT04458129

    Polyethylene Glycol and Intestinal Inflammation in Cystic Fibrosis

    Not yet reported University Hospital, Bordeaux 23 participants Est. completion 2022-07-08 1 site
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Status unknown NCT NCT04460508

    Mecapegfilgrastim(PEG-G-CSF) for Prophylaxis of Chemotherapy-induced Neutropenia in Patients With Lymphoma

    Not yet reported The First Hospital of Jilin University 170 participants Est. completion 2023-03-20 1 site
    Other conditions: Chemotherapy-induced Neutropenia, Lymphoma
    View official trial listing →
  • Completed NCT NCT04466137

    Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

    Not yet reported Xiamen Amoytop Biotech Co., Ltd. 398 participants Est. completion 2021-09-01 1 site
    Other conditions: Non-Myeloid Malignancy
    View official trial listing →
  • Completed NCT NCT04477616

    Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 160 participants Est. completion 2022-11-06 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT04484857

    Study of Roxadustat Conversion in Participants Receiving Stable ESA or as Initial Anemia Treatment in Hemodialysis Participants

    Not yet reported Kyntra Bio 283 participants Est. completion 2021-09-17 26 sites
    Other conditions: Anemia Associated With End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT04504370

    Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects

    Not yet reported PegBio Co., Ltd. 273 participants Est. completion 2022-11-28 1 site
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT04525170

    Clinical Evaluation of HPT Treated Rigid Contact Lenses Made From Hexafocon A

    Not yet reported Contamac Ltd Est. completion 2015-12 2 sites Stand-alone
    Other conditions: Ametropia
    View official trial listing →
  • Completed NCT NCT04525560

    Efficacy, Safety and Tolerability of Different Bowel Preparation Before Colonoscopy in Children Over 2 Years Old

    Not yet reported Children's Hospital of Fudan University 315 participants Est. completion 2021-05-30 1 site Stand-alone
    Other conditions: Child Obesity, Bowel Preparation
    View official trial listing →
  • Completed NCT NCT04534465

    Study to Gather Information on the Acceptability of a New Flavor System With Increasing Levels of 2, 4, 6 g or Higher of Mannitol for PEG 3350 in Subjects Having Infrequent Bowel Movements.

    Not yet reported Bayer 50 participants Est. completion 2013-03-19 1 site
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT04542356

    Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer

    Not yet reported Chongqing University Cancer Hospital 60 participants Est. completion 2021-05-26 1 site Stand-alone
    Other conditions: Cervical Cancer
    View official trial listing →
  • Completed NCT NCT04554056

    Trial to Compare the Efficacy and Safety Of MW05 and PEG-rhG-CSF

    Not yet reported, Not yet reported Mabwell (Shanghai) Bioscience Co., Ltd. 586 participants Est. completion 2022-11-05 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Status unknown NCT NCT04566367

    Blue Laser Imaging (BLI) for Detection of Secondary Head and Neck Cancer

    Not yet reported Georg Dultz 140 participants Est. completion 2024-08-31 1 site
    Other conditions: Head Neck Cancer, Esophageal Cancer, Gastrostomy
    View official trial listing →
  • Status unknown NCT NCT04569890

    Treatment of Pregnancy RA

    Not yet reported RenJi Hospital 100 participants Est. completion 2023-12-01 1 site
    Other conditions: Rheumatoid Arthritis, Pregnancy Related
    View official trial listing →
  • Completed NCT NCT04572906

    Safety and Efficacy of NTX-001 Compared to SOC in Acute Single Peripheral Nerve Injuries

    Not yet reported Neuraptive Therapeutics Inc. 51 participants Est. completion 2024-06-27 10 sites Stand-alone
    Other conditions: Peripheral Nerve Injuries
    View official trial listing →
  • Status unknown NCT NCT04583111

    The Effect of Antiemetics on Bowel Preparation Before Colonoscopy

    Not yet reported RenJi Hospital 200 participants Est. completion 2022-03-01 1 site Stand-alone
    Other conditions: Bowel Preparation
    View official trial listing →
  • Terminated NCT NCT04585542

    Comparison of Potassium Binders in the ER

    Not yet reported University of California, Irvine 37 participants Est. completion 2025-01-31 1 site Stand-alone
    Other conditions: Acute Hyperkalemia, Oral Potassium Binders
    View official trial listing →
  • Completed NCT NCT04605432

    FFI and PR Could Improve Bowel Cleansing.

    Not yet reported Ningbo No. 1 Hospital 320 participants Est. completion 2021-10-27 1 site Stand-alone
    Other conditions: Bowel Preparation
    View official trial listing →
  • Status unknown NCT NCT04610476

    Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

    Not yet reported University of Erlangen-Nürnberg Medical School 270 participants Est. completion 2025-10-19 1 site
    Other conditions: Psoriatic Arthritis, Withdrawal, Reduction
    View official trial listing →
  • Status unknown NCT NCT04627844

    Time to Feeding After PEG Tube Placement.

    Not yet reported Augusta University 500 participants Est. completion 2023-05 Stand-alone
    Other conditions: Feeding Tube Complication
    View official trial listing →
  • Status unknown NCT NCT04708366

    Colon Cleansing Efficacy With 1L vs. 2L vs. 4L-PEG for Colonoscopy Among Inpatients

    Not yet reported University of Bologna 846 participants Est. completion 2022-05-15 1 site Stand-alone
    Other conditions: Colon Disease
    View official trial listing →
  • Completed NCT NCT04745910

    Pegloticase for the Reduction of Uric Acid in Patients With Tumor Lysis Syndrome

    Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2026-04-27 1 site
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Tumor Lysis Syndrome
    View official trial listing →
  • Completed NCT NCT04759885

    Efficacy and Safety of mAnnitol in Bowel Preparation During Elective Colonoscopy and Comparison With Moviprep®

    Not yet reported, Not yet reported NTC srl 886 participants Est. completion 2021-07-16 35 sites
    Other conditions: Elective Colonoscopy
    View official trial listing →
  • Active, not recruiting NCT NCT04789044

    Evaluating the Safety and Efficacy of Polyethylene Glycol (PEG) Mediated Fusion (PEG Fusion)

    Not yet reported Major Extremity Trauma Research Consortium 40 participants Est. completion 2028-10-01 7 sites Stand-alone
    Other conditions: Peripheral Nerve Injuries
    View official trial listing →
  • Status unknown NCT NCT04794049

    Comparison of Oral Lactulose Versus Polyethylene Glycol for Bowel Preparation

    Not yet reported First People's Hospital of Hangzhou 800 participants Est. completion 2021-12-31
    Other conditions: Colon Disease
    View official trial listing →
  • Completed NCT NCT04801303

    Evaluation of the Effects of Calcitriol's in the Neurological Symptoms of Friedreich's Ataxia Patients

    Not yet reported Berta Alemany 20 participants Est. completion 2023-01-31 1 site Stand-alone
    Other conditions: Friedreich Ataxia
    View official trial listing →
  • Completed NCT NCT04878926

    IV Sedation Plus TAP Block for Placement of Percutaneous Endoscopic Gastrostomy Tube

    Not yet reported Damanhour Teaching Hospital 60 participants Est. completion 2018-03-01 1 site
    Other conditions: Transversus Abdominis Plane (TAP) Block
    View official trial listing →
  • Completed NCT NCT04918225

    Motor Asymmetry in Progressive Multiple Sclerosis Patients

    Rennes University Hospital 46 participants Est. completion 2026-02-10 1 site
    Other conditions: Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive
    View official trial listing →
  • Completed NCT NCT04948567

    Efficacy of Split-dose of Oral MMS for Bowel Preparation in Elderly Patients

    Not yet reported Air Force Military Medical University, China 1174 participants Est. completion 2019-12-01 2 sites
    Other conditions: Colonic Adenoma, Bowel Preparation
    View official trial listing →
  • Active, not recruiting NCT NCT05001828

    Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia

    Not yet reported Polaris Group 38 participants Est. completion 2026-12 3 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Adult
    View official trial listing →
  • Completed NCT NCT05028907

    Evaluation of Lacrimal Punctal Changes by Anterior Segment Optical Coherence Tomography AS-OCT After Topical Combined Antibiotics and Steroids Treatment in Cases of Inflammatory Punctual Stenosis

    Not yet reported Sohag University 64 participants Est. completion 2021-07-15 1 site
    Other conditions: Ophthalmopathy , Lacrimal System
    View official trial listing →
  • Completed NCT NCT05076799

    Effect of Lactulose and/or Polyethylene Glycol Solution for Bowel Preparation for Colonscopy Procedures

    Not yet reported Sichuan University 200 participants Est. completion 2022-11-30 1 site Stand-alone
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT05080218

    COVID-19 VaccinE Response in Rheumatology Patients

    Not yet reported Jeffrey Curtis 841 participants Est. completion 2024-05-28 8 sites
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis
    View official trial listing →
  • Completed NCT NCT05084989

    Safety, and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)

    Not yet reported Jiangsu Rec-Biotechnology Co., Ltd. 948 participants Est. completion 2023-02-09 1 site
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT05119452

    Screening for Flare After b/tsDMARD Discontinuation in Rheumatoid Arthritis

    Not yet reported Medical University of Vienna 85 participants Est. completion 2024-09
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05137145

    Effect and Safety of Polyethylene Glycol Combined With Linaclotide on Colon Cleansing for Patients With Chronic Constipation

    Not yet reported Second Affiliated Hospital of Xi'an Jiaotong University 300 participants Est. completion 2022-04-30 1 site
    Other conditions: Bowel Preparation
    View official trial listing →
  • Completed NCT NCT05172999

    Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia

    Not yet reported, Not yet reported Fudan University 30 participants Est. completion 2026-02-28 1 site
    Other conditions: Atypical Endometrial Hyperplasia, Obesity, Fertility Issues
    View official trial listing →
  • Completed NCT NCT05194501

    Unaffected Hand in Hemiplegia

    Ufuk University 90 participants Est. completion 2021-09-05 1 site
    Other conditions: Hemiplegia, Upper Extremity Problem
    View official trial listing →
  • Terminated NCT NCT05215496

    [18F]Fluoro-PEG-folate PET/CT Imaging in Epithelial Ovarian Cancer

    Not yet reported Lioe-Fee de Geus-Oei, MD PhD 5 participants Est. completion 2023-05-01 1 site Stand-alone
    Other conditions: Epithelial Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT05242562

    Effect of Low-volume (1L) vs Intermediate-volume (2L) Bowel Preparation on Cost-effectiveness and Quality of Life

    Not yet reported Radboud University Medical Center 509 participants Est. completion 2023-03-02 1 site Stand-alone
    Other conditions: Colorectal Cancer, Colonic Polyp
    View official trial listing →
  • Completed NCT NCT05244057

    A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients

    Not yet reported Shanghai HEP Pharmaceutical Co., Ltd. 8 participants Est. completion 2024-06-24 1 site Stand-alone
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Completed NCT NCT05340959

    Evaluating Implant Stability Using Three Devices Osstell®, Periotest® and AnyCheck®

    University of Baghdad 16 participants Est. completion 2022-12-01 1 site
    Other conditions: Edentulous Alveolar Ridge
    View official trial listing →
  • Completed NCT NCT05354739

    Comparing Buzzy Device With Emla Cream in Needle Related Pain

    Hamad Medical Corporation 300 participants Est. completion 2021-09-29 1 site
    Other conditions: Procedural Pain
    View official trial listing →
  • Status unknown NCT NCT05357183

    The Study on Clinical Outcome and Treatment Optimization of Chronic Hepatitis B Patients With Hypoviremia

    Beijing Ditan Hospital 1200 participants Est. completion 2024-12 1 site
    Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Withdrawn NCT NCT05379322

    The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients

    Not yet reported Abu Dhabi Stem Cells Center Est. completion 2023-03-01 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT05379491

    Application of Linaclotide Capsule in Bowel Preparation for Patients at High Risk of Inadequate Bowel Preparation

    Not yet reported Zhiguo Liu 720 participants Est. completion 2023-07-15 8 sites
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT05380427

    A Phase I Clinical Trial Evaluating the Safety, Tolerability, and Pharmacokinetics of CU-40101 Liniment in Single and Multiple Doses in Adult Male Androgenic Alopecia Subjects

    Not yet reported Cutia Therapeutics（Wuxi）Co.,Ltd 80 participants Est. completion 2024-02-22 1 site
    Other conditions: AGA
    View official trial listing →
  • Active, not recruiting NCT NCT05386576

    A Study of Venetoclax in Combination With Chemotherapy to Treat Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)

    Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2027-05 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT05397158

    Optimization of Intestinal Preparation in Older Patients

    Not yet reported Beijing Tongren Hospital 312 participants Est. completion 2022-07-31 1 site Stand-alone
    Other conditions: Colonoscopy, Older Adults
    View official trial listing →
  • Status unknown NCT NCT05409547

    A Clinical Study of Autologous Peripheral Blood Stem Cell Mobilization for PEG-G-CSF

    Not yet reported Ning Huang 80 participants Est. completion 2025-04-30 Stand-alone
    Other conditions: Granulocyte Colony-stimulating Factor, Stem Cell Mobilization
    View official trial listing →
  • Completed NCT NCT05424757

    Polyethylene Glycol Safety in Children

    Children's Hospital of Philadelphia 158 participants Est. completion 2025-08-09 1 site
    Other conditions: Polyethylene Glycols, Children, Only
    View official trial listing →
  • Completed NCT NCT05428917

    Evaluation of the Impact of Laterality on Cerebral Activation During a Motor Task of the Upper Limb in Healthy Subjects

    Not yet reported Centre Hospitalier Régional d'Orléans 59 participants Est. completion 2022-05-06 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT05446285

    Multiple Sclerosis Outcome Determination Evaluating Real Differences After TimE

    NHS Greater Glasgow and Clyde 245 participants Est. completion 2023-08 1 site
    Other conditions: Relapsing Remitting Multiple Sclerosis
    View official trial listing →
  • Status unknown NCT NCT05531279

    A Study of PEG-rhG-CSF and rhG-CSF Used for Aplastic Anemia Granulocyte Deficiency

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 45 participants Est. completion 2026-01-05 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT05570669

    Evaluation of Two Different Regimens of Colon Preparations for Advanced Cleaning.

    Not yet reported Societa Italiana di Endoscopia Digestiva 321 participants Est. completion 2021-12-28 10 sites
    Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT05612581

    A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection

    Not yet reported, Not yet reported Vir Biotechnology, Inc. 33 participants Est. completion 2025-08-19 15 sites Stand-alone
    Other conditions: Hepatitis B, Chronic
    View official trial listing →
  • Completed NCT NCT05645458

    The Effect of the Mobile Application for Caregivers of Patients With Percutaneous Endoscopic Gastrostomy (PEG) on Caregivers

    Not yet reported Duzce University 27 participants Est. completion 2024-06-01 1 site Stand-alone
    Other conditions: Percutaneous Endoscopic Gastrostomy, Caregiver Burden, Mobile Application
    View official trial listing →
  • Active, not recruiting NCT NCT05664477

    PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition

    Not yet reported Roberta Brinton 100 participants Est. completion 2027-01-31 2 sites
    Other conditions: Menopause, Cognitive Change, Brain Disorder, Metabolic
    View official trial listing →
  • Status unknown NCT NCT05677945

    3Mixtatin Versus Modified 3Mix-MP in Lesion Sterilization and Tissue Repair for Treatment of Necrotic Primary Molars

    Not yet reported Cairo University 24 participants Est. completion 2024-08
    Other conditions: Necrotic Primary Molars
    View official trial listing →
  • Completed NCT NCT05679973

    Evaluation of the Efficacy of Polybutester Suture on Postoperative Complications in Lower Impacted Third Molar Surgery

    Not yet reported Yuzuncu Yil University 35 participants Est. completion 2020-09-01 1 site
    Other conditions: Impacted Third Molar Tooth
    View official trial listing →
  • Status unknown NCT NCT05700981

    Colon Capsule Endoscopy in Patients With Colonic Diverticulitis

    Not yet reported Odense University Hospital 120 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Diverticulitis, Colonic
    View official trial listing →
  • Completed NCT NCT05755620

    A Study to Evaluate the Safety and Immunogenicity of a Single Dose of H1ssF-3928 mRNA-LNP in Healthy Adults

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 50 participants Est. completion 2025-10-03 1 site Stand-alone
    Other conditions: Influenza
    View official trial listing →
  • Completed NCT NCT05906693

    The Quality of Life in Individuals With Parkinson's Disease

    Pamukkale University 52 participants Est. completion 2021-07-13 1 site
    Other conditions: Parkinson Disease, Tremor, Functionality
    View official trial listing →
  • Status unknown NCT NCT05920213

    Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

    Not yet reported Jinnah Postgraduate Medical Centre 360 participants Est. completion 2024-04 6 sites Stand-alone
    Other conditions: Hepatic Encephalopathy Stage 2, Hepatic Encephalopathy Stage 3, Hepatic Encephalopathy Stage 4
    View official trial listing →
  • Completed NCT NCT05935878

    Cemented Versus Cementless Unicompartmental Knee Arthroplasty

    Not yet reported Oxford University Hospitals NHS Trust 47 participants Est. completion 2022-03-11 Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT05973409

    Evaluation of Onefit Scleral Lenses in the Mangement of Dry Eye

    Not yet reported CooperVision International Limited (CVIL) 46 participants Est. completion 2023-08-15 1 site Stand-alone
    Other conditions: Dry Eye
    View official trial listing →
  • Withdrawn NCT NCT06006286

    A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center Est. completion 2023-11-10 1 site Stand-alone
    Other conditions: Metastatic Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT06007417

    A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 162 participants Est. completion 2025-08-01 1 site Stand-alone
    Other conditions: GHD
    View official trial listing →
  • Completed NCT NCT06010459

    Reference Values for the Six-minute Pegboard and Ring Test in Healthy Adults in Turkey

    Ulaş Ar 132 participants Est. completion 2022-11-01 1 site
    Other conditions: Exercise Tolerance
    View official trial listing →
  • Completed NCT NCT06028438

    A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

    Not yet reported Janssen Research & Development, LLC 103 participants Est. completion 2024-10-29 32 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Status unknown NCT NCT06077032

    Chlorhexidine and Garlic Extract as Potential Topical Virucidal Therapeutic Agents of Non-Genital Warts

    Not yet reported Assiut University 90 participants Est. completion 2025-12-01
    Other conditions: Non-Genital Warts
    View official trial listing →
  • Status unknown NCT NCT06099392

    The Effect of Transcutaneous Electrical Acustimulation on Small Bowel Preparation for Capsule Endoscopy

    Not yet reported Shanghai Changzheng Hospital 166 participants Est. completion 2024-12-01
    Other conditions: Quality of Small Bowel Preparation
    View official trial listing →
  • Completed NCT NCT06132165

    Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas

    Not yet reported Massachusetts General Hospital 13 participants Est. completion 2025-07-31 1 site
    Other conditions: Neurofibromatosis 1
    View official trial listing →
  • Status unknown NCT NCT06158451

    Clinical and Radiographic Evaluation of Zinc Oxide-Propolis Mixture Versus Modified Triple Antibiotic Paste in LSTR

    Not yet reported Cairo University 40 participants Est. completion 2025-01-31
    Other conditions: Pain, Postoperative, Periapical; Infection
    View official trial listing →
  • Completed NCT NCT06159777

    Pre-operative Polyethylene Glycol 3350 for Minimally Invasive Urogynecologic Surgery

    Not yet reported University Hospitals Cleveland Medical Center 72 participants Est. completion 2026-03-13 1 site Stand-alone
    Other conditions: Constipation, Surgical Procedure, Unspecified, Prolapse; Female
    View official trial listing →
  • Status unknown NCT NCT06168188

    The Neuroprotective Effect of PEG-GCSF in the Traumatic Optic Neuropathy

    Not yet reported Buddhist Tzu Chi General Hospital 20 participants Est. completion 2024-12-31 1 site
    Other conditions: Traumatic Optic Neuropathy
    View official trial listing →
  • Completed NCT NCT06192472

    Investigation Into the Pathophysiology and Treatment of Varicose Veins

    Not yet reported University of Surrey 120 participants Est. completion 2015-09 2 sites
    Other conditions: Varicose Veins
    View official trial listing →
  • Completed NCT NCT06282367

    Bowel Preparation for Colonoscopy With Oral Lactulose

    Josue Aliaga 222 participants Est. completion 2023-04-01 1 site
    Other conditions: Colonoscopy, Colonoscopy Preparation
    View official trial listing →
  • Status unknown NCT NCT06313242

    Different Bowel Preparations in Magnetically Controlled Capsule Endoscopy

    Not yet reported Qilu Hospital of Shandong University 375 participants Est. completion 2025-06 1 site
    Other conditions: Magnetically Controlled Capsule Endoscopy, Bowel Preparation
    View official trial listing →
  • Completed NCT NCT06380699

    Study to Assess PK, Safety and Tolerability in Healthy Subjects

    Not yet reported Changzhou Qianhong Bio-pharma Co., Ltd. 56 participants Est. completion 2023-12-25 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06395597

    Variability of Healthy People and People After Stroke Results in the Nine Hole Peg Test

    Charles University, Czech Republic 40 participants Est. completion 2023-12-30 2 sites
    Other conditions: Motor Activity
    View official trial listing →
  • Completed NCT NCT06404853

    Effect and Safety of the Dietary Supplement Mannite in Pediatric Patients With Chronic Functional Constipation

    Not yet reported Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria 110 participants Est. completion 2023-12-31 1 site
    Other conditions: Constipation - Functional
    View official trial listing →
  • Status unknown NCT NCT06486038

    Quatitative MRI of the Spinal Cord in Cervical Myelopathy: Assessment of Microstuctural Damage for Outcome Improvement

    Not yet reported Istituto Clinico Humanitas 100 participants Est. completion 2025-05-31 1 site Stand-alone
    Other conditions: Cervical Myelopathy
    View official trial listing →
  • Active, not recruiting NCT NCT06491563

    Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)

    Not yet reported Brii Biosciences Limited 150 participants Est. completion 2027-06 12 sites Stand-alone
    Other conditions: For Treatment of Chronic Hepatitis B Virus Infection
    View official trial listing →
  • Status unknown NCT NCT06495476

    Study on Ginkgo Biolba Extract Fifty and Mild Cognitive Impairment Associated With CSVD

    Not yet reported Beijing Tiantan Hospital 144 participants Est. completion 2026-06-30
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT06551883

    Comparison of Split-dose and Single-dose Bowel Preparation Regimens Using Polyethylene Glycol Electrolyte(PEG)

    Not yet reported Tongji Hospital 101 participants Est. completion 2021-06-20 1 site Stand-alone
    Other conditions: Bowel Preparation
    View official trial listing →
  • Active, not recruiting NCT NCT06586437

    Neuromodulation of the Cortex and Spinal Cord

    Not yet reported Father Flanagan's Boys' Home 50 participants Est. completion 2029-08 1 site Stand-alone
    Other conditions: Cerebral Palsy
    View official trial listing →
  • Completed NCT NCT06698861

    A Phase I PK/PD Study of PEG-MetHuG-CSF (P2203) in Healthy Volunteers

    Not yet reported PharmaEssentia 30 participants Est. completion 2025-02-06 1 site Stand-alone
    Other conditions: PK in Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT06728839

    Efficacy, Safety and Tolerability of Magnesium Sulfate With Low-volume Polyethylene Glycol for Colonoscopy Cleansing

    Not yet reported Changhai Hospital 1329 participants Est. completion 2025-08-31 Stand-alone
    Other conditions: Bowel Preparation for Colonoscopy
    View official trial listing →
  • Completed NCT NCT06750445

    Fluoxetine for Refractory Constipation

    Not yet reported Zhifeng Zhao, PhD 316 participants Est. completion 2025-05-30 3 sites Stand-alone
    Other conditions: Refractory Constipation
    View official trial listing →
  • Enrolling by invitation NCT NCT06777173

    Clinical Study of Antiviral Therapy Combined With Novel Immunotherapy for CHB in Adults

    Not yet reported Beijing Ditan Hospital 180 participants Est. completion 2026-11-01 1 site Stand-alone
    Other conditions: Chronic Hepatitis b, Immunotherapy
    View official trial listing →
  • Not yet recruiting NCT NCT06840691

    A Bioequivalence Study of Two Different Processes of PEG-rhGH Preparations

    Not yet reported Changchun GeneScience Pharmaceutical Co., Ltd. 87 participants Est. completion 2025-09 1 site Stand-alone
    Other conditions: Pediatric Growth Hormone Deficiency (PGHD)
    View official trial listing →
  • Not yet recruiting NCT NCT06863363

    PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults

    Not yet reported Shanghai Zhongshan Hospital 212 participants 1 site Added to GLP-1
    Other conditions: Non-diabetic Obesity
    View official trial listing →
  • Completed NCT NCT06893796

    Safety, Tolerability, and PK/PD of Telpegfilgrastim in Premenopausal Non-pregnant Females

    Not yet reported Xiamen Amoytop Biotech Co., Ltd. 18 participants Est. completion 2025-05-08 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Not yet recruiting NCT NCT06896058

    Effect of ınformatıon to caregıvers of Stroke patıents wıth Percutaneous endoscopıc Gastrostomy

    Not yet reported Cukurova University 60 participants Est. completion 2025-07-15
    Cardiovascular disease
    View official trial listing →
  • Enrolling by invitation NCT NCT06908226

    A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)

    Not yet reported Longboard Pharmaceuticals 324 participants Est. completion 2027-12-17 83 sites Stand-alone
    Other conditions: Developmental and Epileptic Encephalopathy
    View official trial listing →
  • Completed NCT NCT06916689

    Efficacy And Tolerability Of Asymmetric Split Regimen For Bowel Preparation

    Not yet reported ASST Rhodense 236 participants Est. completion 2024-10-10 1 site Stand-alone
    Other conditions: Colon Preparation, Polyps Colorectal
    View official trial listing →
  • Active, not recruiting NCT NCT06917638

    Dental Implant Stability Placed in Healed Bony Sites Using Oversized Drilling Versus Conventional Drilling Protocol

    Not yet reported Cairo University 26 participants Est. completion 2026-05-20 1 site
    Other conditions: Implant Complication
    View official trial listing →
  • Completed NCT NCT06924385

    Safety, Tolerability, and PK/PD of Telpegfilgrastim Injection in Non-pregnant Females of Childbearing

    Not yet reported Xiamen Amoytop Biotech Co., Ltd. 18 participants Est. completion 2026-01-20 1 site
    Other conditions: Preeclampsia
    View official trial listing →
  • Not yet recruiting NCT NCT07071636

    Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients

    Not yet reported Shenzhen Third People's Hospital 830 participants Est. completion 2029-09-30 Stand-alone
    MASLD Other conditions: Chronic Hepatitis B
    View official trial listing →
  • Not yet recruiting NCT NCT07072585

    Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)

    Not yet reported, Not yet reported Children's Oncology Group 1708 participants Est. completion 2035-09-01
    Other conditions: Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma, Stage IV T Lymphoblastic Leukemia/Lymphoma, T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma
    View official trial listing →
  • Completed NCT NCT07084350

    Combination of Lactulose and Polyethylene Glycol Electrolytes Powder (PEG-ELS) for Bowel Preparation in Type II Diabetes Mellitus Patients

    Not yet reported General Hospital of Shenyang Military Region 300 participants Est. completion 2026-05-18 1 site Stand-alone
    Other conditions: Type II Diabetes Mellitus
    View official trial listing →
  • Not yet recruiting NCT NCT07127237

    Prucaloprida vs Bisacodyl as a Stimulant in Bowel Preparation for Video Colonoscopy in Adults

    Not yet reported Hospital de Clínicas Dr. Manuel Quintela 124 participants Est. completion 2026-02 Stand-alone
    Other conditions: Bowel Preparation
    View official trial listing →
  • Not yet recruiting NCT NCT07435896

    Impact of Information and Participation on Decision Time for Tracheostomy or PEG in ICU Families

    Elazıg Fethi Sekin Sehir Hastanesi 60 participants Est. completion 2026-06-15
    Other conditions: Intensive Care Unit (ICU) Admission, Tracheostomy, Percutaneous Endoscopic Gastrostomy (PEG)
    View official trial listing →
  • Not yet recruiting NCT NCT07499336

    UNDERSTANDING THE T-CELL AND B-CELL RECEPTOR REPERTOIRE IN CHILDREN AND YOUNG ADULTS WITH ANTI-DRUG ANTIBODIES AGAINST PEG ASPARAGINASE

    Aarhus University Hospital 45 participants Est. completion 2030-01-31
    Other conditions: Acute Lymphoblastic Leukaemia - Category
    View official trial listing →
  • Not yet recruiting NCT NCT07537387

    A Study on the Pursuit of Sustained Clearance of HBsAg in Chronic Hepatitis B(CHB) Patients With Previous Interferon Treatment Using Pegylated Interferon Alpha

    xieqing 10000 participants Est. completion 2030-12-31 1 site
    Other conditions: Chronic Hepatitis b
    View official trial listing →
  • Not yet recruiting NCT NCT07553416

    Prospective, Randomized, Parallel-Controlled Study of Brain Computer Interface Integrated Robotic Mirror Therapy for Post-Stroke Upper Limb Motor Function Disorder

    Not yet reported Beijing Tiantan Hospital 40 participants Est. completion 2027-12-31 1 site
    Cardiovascular disease Other conditions: Intracranial Haemorrhage, Brain-Computer Interfaces, Rehabilitation Exercise
    View official trial listing →
  • Completed NCT NCT07555847

    Effect of Kinesiotaping on Tremor in People With Parkinson's Disease

    Not yet reported Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey 45 participants Est. completion 2026-01-01 1 site
    Other conditions: PARKINSON DISEASE (Disorder), Tremor, Tremor Associated With Tremor Dominant Parkinson's Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07604025

    Senna vs. Polyethylene Glycol 3350 for the Treatment of Retentive Encopresis in Children

    Not yet reported Shaare Zedek Medical Center 80 participants Est. completion 2028-01-01 2 sites
    Other conditions: Encopresis With Constipation and Overflow Incontinence
    View official trial listing →
  • Not yet recruiting NCT NCT07636564

    Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment

    Not yet reported SWOG Cancer Research Network 90 participants Est. completion 2032-04-16
    Other conditions: Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, T Acute Lymphoblastic Leukemia
    View official trial listing →
  • Not yet recruiting NCT NCT07647185

    Caregiver Training Regarding Percutaneous Endoscopic Gastrostomy Feeding and Care

    Not yet reported Duzce University 54 participants Est. completion 2027-03-30 Stand-alone
    Other conditions: Caregiver, Caregiver Anxiety, Simulation Training, State Anxiety, Nursing Care, Video-Assisted, Percutaneous Endoscopic Gastrostomy (PEG), Training
    View official trial listing →
  • Enrolling by invitation NCT NCT07829276

    Study on the Efficacy and Safety of Different Doses of PEG-rhG-CSF for Primary Prevention of Febrile Neutropenia

    Zhejiang Provincial People's Hospital 350 participants Est. completion 2027-12-31 1 site
    Other conditions: Malignant Tumor
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Polyethylene Glycol 3350, PEG 3350 and Electrolytes, PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID, PEG 3350, sodium chloride, sodium bicarbonate and potassium chloride, PEG, PEG (solution given 4 L)

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.